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Abstract 
Despite many health reforms, the United States continues to struggle with limited 
healthcare access, exponential healthcare costs, and poor quality of care. Overcoming 
these challenges requires healthcare leaders’ effective navigation of industry 
transformation towards population health and a shift in patient volume to ambulatory 
healthcare settings. Research has demonstrated that the use of managerial epidemiology, 
an application of epidemiology tools and principles to management decision-making 
within healthcare organizations, can better serve the health of the population and could 
improve the triple aim of inadequate access, high costs, and poor quality. However, the 
adoption of this practice is weak and its utilization by current healthcare leaders has not 
yet been studied. Diffusion of innovation theory framed this qualitative study to 
understand the perspectives of ambulatory healthcare leaders on using managerial 
epidemiology within their leadership approach as well as understand the spread of this 
practice and associated barriers. Twelve healthcare leaders participated in semistructured 
interviews. Findings from open-axial coding of the interview data indicated managerial 
epidemiology is critical and validated the importance of managerial epidemiology for 
impacting the triple aim, population health, and overall system performance. 
Additionally, this study provided steps to accelerate the adoption and highlighted the use 
of managerial epidemiology during a pandemic, which has worldwide implications for 
improving health and performance of healthcare globally therefore promoting social 
change. 
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Chapter 1: Introduction to the Study 
Introduction 
The United States continues to struggle with limited healthcare access, high costs, 
and suboptimal quality of care.  Although there is a proven practice called managerial 
epidemiology that could help, most academic institutions are not educating healthcare 
leaders on this concept (Caron & Hooker, 2015). In addition, the adoption of this practice 
is weak and there is a lack of published literature on the topic (Fleming, 2015).  
Meanwhile, healthcare leaders are challenged with the triple aim of access, cost, and 
quality (Love & Ayadi, 2015; Storkholm, Mazzocato, Savage, & Savage, 2017).  
Particularly, ambulatory healthcare leaders could benefit from using a population-based 
leadership approach with managerial epidemiology as patient volume is shifting toward 
the ambulatory healthcare settings (Love & Ayadi, 2015; Storkholm et al., 2017).  The 
intent of this study was to gain an understanding of ambulatory healthcare leaders’ 
perspectives on the use of managerial epidemiology.  The findings of this study may 
provide insight to changing healthcare leadership approaches to improve the health of 
populations and enhance the performance of healthcare organizations. 
In Chapter 1, I provide a description of the background of this study and state the 
problem this study will address, the research questions to be explored, and the framework 
guiding the research.  In addition, I provide definitions of key concepts, an overview of 
the scope, and the limitations.  At the end of Chapter 1, the significance of this study is 
shared before transitioning into the literature review in Chapter 2.  
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Background of Study 
Compared to other countries, the United States has struggled with access, cost, 
and quality of healthcare for its population (Osborn, Squires, Doty, Sarnak, & Schneider, 
2016).  This national healthcare challenge requires a change to healthcare leadership 
approaches.  Combining epidemiology with healthcare management may improve the 
health of populations and help solve the nation’s challenges of excessive costs, limited 
access, and inadequate quality in healthcare (Ibrahim, 1983; Scutchfield & Keck, 2009).  
This combination of epidemiology and healthcare management is called managerial 
epidemiology (Fleming, 2015; Rohrer, 2013).  This practice is not commonly known or 
researched.  As this practice is emerging, approximately 20% of healthcare leaders are 
retiring (Grimm, Watanabe-Galloway, Britigan, & Schmaker, 2015).  Although new 
leaders are entering the workforce, most academic programs do not offer a curriculum 
including managerial epidemiology (Caron & Hooker, 2011).  Therefore, emerging 
leaders are not adequately trained for the significant changes needed for our healthcare 
industry (Caron & Hooker, 2011).  Healthcare managers are constantly challenged by the 
triple aim of cost, access, and quality, but it will be more important than ever for 
ambulatory healthcare leaders to use managerial epidemiology as the healthcare approach 
towards preventative medicine shifts the patient volume to ambulatory healthcare settings 
(Love & Ayadi, 2015; Storkholm et al., 2017). 
Problem Statement 
Despite healthcare reform attempts such as those led by Presidents Roosevelt, 
Clinton, and Obama, the same challenges of poor quality, limited access to services, and 
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high costs continue to plague the nation and create a complex environment for healthcare 
leaders to generate improvements (Osborn, et al., 2016; Storkholm et al., 2017).  
Decisions informed through patient population data could contribute to improvements in 
the nation's health and economy by reducing costs, increasing access to, and reducing the 
use of services while improving quality of care (Fleming, 2013).  Fleming (2013) and 
Rohrer (2013) have promoted a blend of healthcare administration and epidemiology 
called managerial epidemiology.  Using managerial epidemiology, healthcare leaders 
could make decisions to better serve the health needs of their patient population 
(Fleming, 2015).  Caron and Hooker (2011) indicated that healthcare leadership 
education and training is not consistently adequate for the changes the healthcare industry 
has faced, such as the noted shift in public health from infectious to population health, 
and the increased triple threat of access, cost, and quality.  This is attributed to a gap in 
education programs providing education in managerial epidemiology topics (Caron & 
Hooker, 2011). Although there is a managerial epidemiology textbook developed by 
Fleming (2015) with case studies to help health services leaders adopt the practice, as 
well as supplemental resources for teaching, few health services undergraduate and 
graduate education programs offer managerial epidemiology courses or concepts and 
adoption of the practice is still weak (Caron & Hooker, 2011; Rohrer, Angstman, & 
Pecina, 2013).   
Despite this acknowledgment that managerial epidemiology is a promising 
practice for healthcare leaders and that education for healthcare leaders is inconsistent, 
the engagement and perspectives of ambulatory leaders for using the practice to navigate 
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the ongoing national healthcare challenges is unclear.  After almost 40 years, only a small 
number researchers make up the managerial epidemiology research community.  These 
researchers indicate that the practice will help healthcare leaders improve population 
health and reduce the burden of access, cost, and quality (Caron & Hooker, 2015; 
Fleming, 2015).  However, there is a lack of published literature on leaders’ 
understanding of and use of managerial epidemiology in ambulatory healthcare settings.  
Rohrer, Angstman, and Pecina (2013) emphasized the need for further development of 
managerial epidemiology and encouraged healthcare leaders to consider using it.  With 
the evident benefits of the concept of managerial epidemiology and recognition of the 
weak adoption, it is surprising that leaders’ perspectives of managerial epidemiology are 
presently unstudied as to identifying recommendations for increased use of the practice.  
The health of our nation may become reliant on healthcare leaders understanding and 
utilizing the practice of managerial epidemiology. Therefore, the perspectives of 
ambulatory leaders on the use of and diffusion of managerial epidemiology should be 
studied to address this gap. 
Purpose of Study 
The purpose of this traditional qualitative study is to understand perspectives on 
the use of and diffusion of managerial epidemiology among healthcare leaders with 
experience in ambulatory healthcare settings.  Collection and analysis of interview data 
can stimulate a greater understanding of the current experiences ambulatory leaders have 
in using managerial epidemiology to guide their practice, such as development and 
implementation of staffing models, new services, or modes of health service delivery.  
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This data may provide insight into how managerial epidemiology can be used to lead an 
effective, efficient healthcare organization, as well as improve the health of the patient 
population the organization serves. 
Research Questions 
The following research questions guided this study:  
Research Question 1: What are the perspectives and experiences of ambulatory 
healthcare leaders on the use of managerial epidemiology for decision-making?   
Subquestion 1: What are the perspectives and experiences of healthcare leaders in 
ambulatory healthcare settings on the relative advantage of the use of managerial 
epidemiology? 
Subquestion 2: What are the perspectives and experiences of healthcare leaders in 
ambulatory healthcare settings on the compatibility of the use of managerial 
epidemiology? 
Subquestion 3: What are the leaders’ perspectives and experiences of healthcare 
leaders in ambulatory healthcare settings on the complexity of the use of managerial 
epidemiology? 
Subquestion 4: What are the perspectives and experiences of healthcare leaders in 
ambulatory healthcare settings on the trialability of the use of managerial epidemiology? 
Research Question 2: What are the perspectives and experiences of ambulatory 
healthcare leaders regarding communicating the use of managerial epidemiology through 
the healthcare system? 
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Framework 
The framework for this research study is diffusion of innovation (DoI) theory 
(Rogers, 2003).  DoI theory, developed by Rogers in 1962, considers four elements for 
diffusion of an innovation: the innovation itself, communication, time, and social system 
(Rogers, 2003).  Additionally, the main attributes of influencing an innovation from the 
DoI theory (i.e., relative advantage, compatibility, complexity, trialability, and 
observability; Rogers, 2003) were explored through this study of managerial 
epidemiology.  These attributes are defined as follows: 
• Relative advantage describes whether the innovation, such as managerial 
epidemiology, is viewed as being beneficial (Rogers, 2003).  This can be 
explored by determining whether the healthcare leaders in ambulatory 
healthcare settings perceive the practice of managerial epidemiology to be a 
benefit to their decision-making or a hindrance.   
• Compatibility refers to whether the innovation fits well with the current norms 
to understand the speed and needs of the adoption (Rogers, 2003).  Through 
the compatibility lens, I explored how managerial epidemiology links with 
current norms and practices especially as it related to managers’ decision-
making and improvement processes.   
• Rogers (2003) described the attribute of complexity as being used to assess 
the perceived difficulty of the innovation.  In this study, I assessed perceptions 
of the difficulty of applying the concept of managerial epidemiology in 
leadership practices as well.   
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• Trialability is used to understand whether the innovation can be used as a trial 
or experiment prior to adoption (Rogers, 2003).  I explored the leaders’ 
willingness and ability to try the use of the managerial epidemiology practice 
to understand this element of diffusion.   
• Lastly, observability refers to the measure of how much the innovation can be 
viewed by the adopters to understand the results and benefits of the innovation 
to help with adoption (Rogers, 2003).  Exploring the leaders’ perspectives 
helped glean whether the practice can be observed before full adoption and 
how this might be done to increase diffusion of managerial epidemiology.  
In this research, the DoI theory related to the adoption of managerial 
epidemiology as being poor, despite past attempts and the perceived benefit of the 
practice.  Using DoI theory allowed me to explore the diffusion of managerial 
epidemiology.  I was able to ask specific questions to assess the leaders’ perceptions of 
the four elements as they relate to managerial epidemiology including, the innovation 
itself, communication, time, and social system, as well as the five aforementioned 
attributes that influence adoption of the innovation.  Drawing from the DoI theory, 
studying the leaders’ perceptions helped to form a better understanding of diffusion of 
managerial epidemiology.  Although the DoI theory has been used in the past for the 
healthcare industry, it had not been used as a framework within the managerial 
epidemiology literature (Huye et al., 2017). 
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Nature of Study 
The nature of this research was traditional qualitative research using interviewing 
as the method of data collection (Ravitch & Carl, 2016).  I conducted this qualitative 
research to gather leaders’ perspectives on managerial epidemiology.  The method for 
data collection was in-person or virtual interviews with ambulatory leaders.  The 
interviews were recorded and manually transcribed.  A thorough coding with preset codes 
and emerging codes, categorizing, and theming was conducted to generate the 
overarching themes related to the managerial epidemiology. 
Definitions 
Ambulatory healthcare setting: A healthcare setting which could include 
community health centers, urgent care centers, outpatient clinics, physician offices, 
specialty clinics or centers, radiology centers, and dental clinics (Centers for Disease 
Control and Prevention, 2016). 
Compatibility: A component of the DoI theory that measures of the alignment of 
the innovation with the existing norms of the adopters and the social system (Rogers, 
2003). 
Complexity: A component of the DoI theory that describes the degree of how 
difficult it is to utilize and understand the innovation (Rogers, 2003). 
Managerial epidemiology: The application of epidemiology principles and tools 
to decision-making within and the management of healthcare organizations (Caron, 
Hooker, & Ulrich-Schad, 2013; Fleming, 2015). 
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Observability: An element of the DoI theory that describes the visibility of 
innovation results (Rogers, 2003).   
Population health: Overall health outcomes of a group including the spread of 
outcomes and determinants of health within the group of individuals (Kindig & Stoddart, 
2003). 
Relative advantage: An element of the DoI theory that describes how the 
innovation is perceived as being better than the idea (Rogers, 2003).   
Trialability: An element of the DoI theory that measures how experimental the 
innovation might be (Rogers, 2003). 
Assumptions 
Prior to the start of this study, a few assumptions were recognized.  One 
assumption encompassed the engagement of healthcare leaders in ambulatory healthcare 
settings.  I assumed the participants would not have much time to spare for the interview.  
I also assumed there may be bias from the participants towards their own experiences and 
managerial practices.  I also assumed that participants would respond as honestly as 
possible. However, there is no way to know in qualitative research whether the 
participant is providing honest answers or telling you what they think you want to hear.   
Scope and Delimitations 
The scope of this study includes the perspectives and experiences of healthcare 
leaders in ambulatory healthcare settings regarding the use of managerial epidemiology.  
There is little literature published on managerial epidemiology, and I found nothing 
exploring its use by healthcare leaders in ambulatory healthcare settings.  Healthcare 
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leaders and organizations can use the perspectives from this study to change leadership 
approaches that may drive organizational performance and improve access, enhance 
quality, and reduce costs of care. 
For delimitations, I chose to include only healthcare leaders in ambulatory 
healthcare settings rather than any healthcare leader.  This delimitation was chosen due to 
the shift of patient volume toward the ambulatory healthcare settings.  Further 
delimitations of the participant pool include the criterion of at least 1 year of experience 
in the ambulatory healthcare settings.  This delimitation is important to ensure that the 
participants have adequate experience to provide a perspective on the topic in the 
ambulatory healthcare setting.  Another delimitation is the conceptual framework of DoI.  
I considered using phenomenology or grounded theory.  However, both were not suitable 
for this research on managerial epidemiology.  The concept itself of managerial 
epidemiology was already developed; therefore, grounded theory was not appropriate.  
The use of phenomenology was also inappropriate as there are likely few lived 
experiences with managerial epidemiology to provide meaningful data.  The concept of 
managerial epidemiology exists, yet there is little experience with the practice, so the use 
of DoI as a conceptual framework provides the most appropriate underpinning to address 
the research question. 
Limitations 
There are a few limitations of this qualitative study to consider.  One readily 
apparent limitation is the use of video or telephone conferencing for some interviews 
instead of conducting an in-person interview.  Although technology allows for connection 
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with participants near and far and reduces costs for the study, technology can limit the 
researcher’s ability to build rapport and experience nonverbal communication (Ravitch & 
Carl, 2016).  Another limitation of this study is the request for participants to become 
familiar with the concept definitions presented in this study and provide their 
perspectives.  If participants are given robust time (i.e., months) to develop perspectives 
on these defined concepts prior to interviewing, their perspectives might be more well-
rounded and developed. Lastly, there is a limitation with generalizing this study.  This 
study was conducted with healthcare leaders in ambulatory healthcare settings only; 
therefore, transferring the findings to other healthcare leaders would need to be critically 
evaluated. 
Significance 
The aim of this study was to understand the perspectives of healthcare leaders in 
ambulatory healthcare settings regarding the use of managerial epidemiology. Managerial 
epidemiology is a concept that may improve population health and organizational 
performance by reducing costs, improving access, and enhancing quality of care.  
Healthcare leaders are struggling to define the meaning of population health and 
significant variation of the concept across many organizations is noted (Skinner, Franz, 
Taylor, Shaw, & Kelleher, 2018).  Yet, population health is the key to improving our 
nation’s healthcare system (Fos, Fine, & Zuniga, 2018).  With academic institutions not 
equipping current and future leaders with applicable population health leadership 
approaches and skills, this study is positioned to provide insight for changing the 
approach of healthcare leaders across the nation to impact the health of the greater 
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population and to improve the performance of healthcare organizations.  Additionally, 
this study can contribute to literature in support of managerial epidemiology to be 
included in academia for future healthcare leaders. 
Summary 
The challenges of limited access, high costs, and suboptimal quality of care 
continue to plague the United States (Osborn et al., 2016; Storkholm et al., 2017).  Using 
a population-based leadership approach and practicing managerial epidemiology can help 
leaders navigate these challenges more effectively (Caron & Hooker, 2015; Fleming, 
2015).  In this study, I explored the perspectives of healthcare leaders in ambulatory 
healthcare settings on using managerial epidemiology to provide recommendations for 
changing the approach of healthcare leaders across the nation, thereby improving the 
health of the greater population and improving the effectiveness of our healthcare system.  
In Chapter 2, I will review literature that supports key concepts and highlights the gap in 
existing literature to be explored in this study.  In Chapter 3, the research design will be 
presented in detail. 
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Chapter 2: Literature Review 
Introduction 
Although the practice of managerial epidemiology can help health systems 
become more effective in improving the access, cost, and quality of healthcare services 
for greater patient populations, it is not widely applied by managers (Fleming, 2015).  
Despite its benefits, managerial epidemiology is not taught within many healthcare 
administration programs (Caron & Hooker, 2011).  Rooted in the theoretical framework 
of DoI, this qualitative research was conducted to gather the perspectives of healthcare 
leaders on the use of managerial epidemiology in ambulatory healthcare settings.  Using 
EBSCO database, the primary search for the literature review included keywords such as 
managerial epidemiology, diffusion of innovations, ambulatory leader, ambulatory 
manager, outpatient leader, and outpatient manager. 
Theoretical Framework 
The theoretical framework for this study, DoI theory, was developed by Rogers in 
1962 (Rogers, 2003).  Rogers (2003) defined an innovation as something new that is 
being adopted.  Although DoI is often used for new technology, an innovation can also be 
a practice such as managerial epidemiology.  Diffusion is the way the innovation is 
spread with communication to individuals (Rogers, 2003).  DoI consists of five attributes: 
relative advantage, compatibility, complexity, trialability, and observability (Rogers, 
2003).  Focus on these attributes can lead to the innovation being adopted more quickly 
(Rogers, 2003).   
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Relative advantage of an innovation describes how the innovation is perceived as 
being better than what already exists (Rogers, 2003).  The relative advantage and rate of 
adoption are correlated.  If the potential adopter perceives the innovation as favorable, the 
rate of adoption will be more rapid (Rogers, 2003).  The relative advantage for the same 
innovation can be different depending on the individual.  For example, a study found that 
nurses’ relative advantage for collaborative team models was higher than the relative 
advantage of the primary care doctors’ relative advantage for the same collaborative team 
models (Vedel et al., 2013).  There are few articles on relative advantage related to 
healthcare leadership.  
Compatibility is a measure of the alignment of the innovation with the existing 
norms of the adopters and the social system (Rogers, 2003).  Compatibility also compares 
the innovation with the needs and previous experience of the adopters and system 
(Rogers, 2003).  If the innovation is not compatible, the adoption rate will be slower 
(Rogers, 2003).  Interestingly, the values, norms, and past experiences for healthcare are 
changing while the innovation of managerial epidemiology is emerging.  Like relative 
advantage, there is little literature on compatibility related to healthcare leadership.  
Many of the compatibility articles related to healthcare were focused on the diffusion of 
new care design models such as embedding community workers into healthcare systems 
(Zulu, Michelo, Hurtig, Kinsman, & Michelo, 2015).  
Complexity refers to the perception of how difficult it is to utilize and understand 
the innovation (Rogers, 2003).  The complexity of the innovation is a factor in the rate of 
adoption.  If the innovation is more difficult, the adoption will be much slower than that 
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of an innovation that is more easily understood (Rogers, 2003).  Research exists on 
medical innovations, healthcare technology, and interventions such as healthy dieting 
interventions (Huye et al., 2017).   
Trialability is the measure of how experimental the innovation might be (Rogers, 
2003).  If the adopters are able to try the innovation, the rate of adoption will be 
accelerated (Rogers, 2003).  The ability to test the innovation reduces uncertainty, which 
contributes to an increased rate of adoption (Rogers, 2003).  Research shows trialability 
as beneficial for patients adopting electronic personal medical record (Emani et al., 
2012).  
Observability refers to the visibility of innovation results (Rogers, 2003).  If the 
adopters are able to see results of the innovation more readily, the likelihood of adoption 
increases (Rogers, 2003).  Similar to trialability, research shows observability as a benefit 
for adoption of personal health records (Emani et al., 2012).  There is also literature on 
observability for preventative measures and interventions such as smoking cessation 
(Windsor et al., 2013).  
Rogers (2003) described diffusion as a communication type that transfers 
information about the innovation through a communication channel.  The communication 
channels can be used for sharing messages to groups of people through mass media such 
as the internet or newspapers, whereas interpersonal communication channels are for two 
or a few people to exchange messages (Rogers, 2003).  Rogers also defined types of 
diffusion as heterophily or homophily, which describes the comparison of the individuals 
involved in the communication.  For example, homophily is the measure of similar 
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qualities between the individuals engaged in communication (Rogers, 2003).  In contrast, 
heterophily is the measure of the differences between the individuals involved in the 
communication, which exist for most diffusion problems (Rogers, 2003).  There is 
research on heterophily and homophily related to diffusion between fashion stylists and 
customers (Saiki, 2015).  In healthcare literature, there is research found on homophily 
communication strategies for HIV prevention (Dearing, 1996). However, literature was 
not found on homophily or heterophily related to healthcare leadership (Dearing, 1996).  
A key element to the diffusion process is time.  According to Rogers (2003), there 
are three focuses of time for diffusion.  Time is related to the innovation-decision 
process, the degree to which a person embraces innovation, and the volume of individuals 
in the system (Rogers, 2013).  The innovation-decision process consists of five steps, 
including knowledge, persuasion, decision, implementation, and confirmation (Rogers, 
2003).  The first step, knowledge, refers to when the innovation is first discovered 
(Rogers, 2003).  Next, persuasion is when the innovation is determined to be favorable or 
unfavorable (Rogers, 2003).  The decision step is when actions are taken for accepting or 
rejecting the innovation (Rogers, 2003).  Once the decision is made, implementation is 
when the individuals are using the innovation (Rogers, 2003).  Lastly, confirmation is 
validation or reassurance of the decision for implementing the innovation (Rogers, 2003).  
Rogers (2003) also indicated the possibility for the innovation decision to be retracted 
based on the last step of confirmation.  The time for each step and the time for 
completing the entire process can vary.  
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The time for completing the innovation process as well as the time it takes for 
volume of individuals to adopt the innovation depends on the individuals’ degree of 
embracing innovation (Rogers, 2003).  Rogers (2003) referred to this quality and element 
of adoption as innovativeness.  Specifically, Rogers defined innovativeness as the degree 
the individual adopts an innovation earlier than others.  Individuals can be grouped into 
five categories based on their innovativeness: innovators, early adopters, early majority, 
late majority, and laggards (Rogers, 2003).  The innovators are the first 2.5% to adopt the 
innovation.  These individuals are highly capable to perform and embrace ambiguity and 
uncertainty.  The innovators are key players in new ideas entering a system and 
beginning the innovation-decision process (Rogers, 2003).  The early adopters are 
respected influencers of the remaining system for adopting the innovation and consist of 
the next 13.5% of adopters (Rogers, 2003).  The early majority consists of the next 34% 
to adopt the innovation before the remainder of the system (Rogers, 2003).  These 
individuals are important connectors for the diffusion process between the early adopters 
and the late adopters but are more deliberate than the early adopters (Rogers, 2003).  The 
late majority are skeptical and require their peers to help influence and generate interest 
in adopting the innovation (Rogers, 2003).  Lastly, the laggards must be certain about the 
innovation’s success before they engage in adoption; therefore, these individuals are the 
last to adopt the innovation (Rogers, 2003).  Engaging adopters in all categories is 
important for diffusion and may require various communication channels and messages 
to do so (Rogers, 2003).  
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The social system itself is where the diffusion occurs.  Rogers (2003) described 
the social system as interrelated units engaged in the diffusion of the innovation.  This 
could be a group of individuals, an organization, or even multiple organizations (Rogers, 
2003).  The particular social structure of the system helps define the types of 
communication needed (Rogers, 2003).  In addition, the social system consists of its own 
norms, which contribute to acceptance of change (Rogers, 2003).  The social system also 
determines the type of innovation decision that will occur (Rogers, 2003).  According to 
Rogers (2003), there are three types of innovation decisions including optional innovation 
decisions, collective innovation decisions, and authoritative innovation decisions.  These 
are characterized by the decision maker for adopting the innovation.  Optional innovation 
decisions are made by an independent individual without engagement of others in the 
system (Rogers, 2003).  In contrast, collective innovation decisions are made by the 
members of the system based on majority agreement with the decision (Rogers, 2003).  
Lastly, authority innovation decisions are those made by someone or a group of 
individuals with power or specific expertise (Rogers, 2003).   
Most literature using DoI focuses on areas including anthropology, sociology, 
education, public health, communication, marketing, and geography (Rogers, 2003).  In 
the healthcare field, most of the literature discusses DoI related to new technology such 
as population management information systems or supplies and medication such as 
anesthesia (Scheer, 2017; Leggott et al., 2016).  No literature was found related to DoI 
and managerial epidemiology.  
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Managerial Epidemiology 
Most decisions by clinical providers are evidence-based. However, managerial 
decisions are not commonly based on evidence (Fleming, 2015).  Managerial 
epidemiology is the blend of healthcare administration and epidemiology (Fleming, 2013; 
Rohrer, 2013).  The use of epidemiology for managerial decisions could improve the 
health of populations (Fleming, 2015).  The shift of focus from managing individuals to 
managing populations requires the role of management to also shift to a population-based 
model (Fos et al., 2018).  By understanding the needs of the community and how to 
provide the appropriate services, managers can make decisions on planning and 
evaluation of their health care delivery organization (Caron & Hooker, 2011).  
Additionally, managerial epidemiology can be used to measure the effectiveness of a 
healthcare system (Caron & Hooker, 2011).  The use of managerial epidemiology is 
urged as pressure builds for cost-containment and improved quality of care (Fos et al., 
2018).  Literature shows managerial epidemiology can be an essential discipline to 
achieve population objectives (Fos et al., 2018).  Though little research has been 
conducted on managerial epidemiology, the application has been successful for quality 
improvement and demonstrates the need for education in the subject before students join 
the healthcare workforce.   
Quality Improvement 
Quality improvement is often a responsibility of healthcare managers (Rohrer, 
Angstman, & Pecina, 2013).  Managerial epidemiology can assist managers in evaluating 
and making decisions for improved quality of care and services. By using epidemiology 
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analyses, including evaluation of the person, place, and time, managers can plan and 
evaluate quality improvement projects more effectively (Rohrer, Grover, & Moats, 2013).  
Studies have tested the application of managerial epidemiology for quality improvement 
initiatives such as evaluating antibiotic prescribing for respiratory infections and 
effectiveness of care management for depression (Rohrer, Angstman, & Pecina, 2013; 
Rohrer, Grover, & Moats, 2013).  Researchers suggest health services managers use 
managerial epidemiology for quality improvement (Rohrer, Angstman, & Pecina, 2013; 
Rohrer, Grover, & Moats, 2013). 
Academics 
University leaders indicate that healthcare administrators should be competent in 
areas related to population health (Caron & Hooker, 2015; Hooker et al., 2017).  
However, undergraduate and graduate healthcare administration programs are 
inconsistently providing education on managerial epidemiology, or epidemiology topics 
to develop this competency (Caron & Hooker, 2011).  Despite the known benefits of 
using managerial epidemiology, a course on the subject is only offered in approximately 
50% graduate programs and less than 20% of undergraduate programs (Caron & Hooker, 
2011).  The absence of this course in a curriculum is due to competing content without 
enough capacity, lack of resources, no certification or licensure requirement associated 
with managerial epidemiology, and some components being taught elsewhere in the 
current curriculum (Caron & Hooker, 2011).  Education in managerial epidemiology 
assists in shifting perspectives to a population-approach and underlines the need for 
managers to be adaptable (Caron & Hooker, 2011).  Textbooks have been created to help 
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encourage the application of managerial epidemiology and the leadership required 
(Fleming, 2015). 
Ambulatory Healthcare Leadership 
Ambulatory is a healthcare setting to provide care to patients who are not hospital 
bound.  Ambulatory care includes areas such as primary and specialty physician offices, 
radiology or other diagnostic testing centers, urgent care, outpatient centers, and dental 
offices (Centers for Disease Control and Prevention, 2016).  Due to public health 
attention shifting from infectious disease to preventative care, wellness and population 
health, the patient populations and scope of ambulatory care continues to expand 
(Scutchfield & Keck, 2009). 
Healthcare leader responsibilities include decision making for planning, staffing, 
and directing of their areas of accountability in the healthcare organization (Fleming, 
2013).  Healthcare leaders may hold a master’s in healthcare administration, master’s in 
public health, master’s in business administration, or may be nursing professionals (Love 
& Ayadi, 2015).  In addition, there are multiple competency models for healthcare 
leaders including a those shared by American College of Healthcare Executives and 
National Center for Healthcare Leadership (e.g., Love & Ayadi, 2015).   
In the ambulatory healthcare setting, leaders must execute planning, staffing, 
directing, as well as other management functions, and balance the triple aim of cost, 
quality, and access in an environment with an increasing patient volume.  According to 
Mahbanooei, Gholipour, and Ardakan (2016), some of the core competencies for 
healthcare leaders include knowledge and awareness, intelligence and talent, values and 
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attitudes, personality traits, communication skills, decision-making skills, leadership, and 
management abilities.  Literature also suggests emotional intelligence is another 
competency healthcare leaders should have (Weiszbrod, 2015).  The public health shift 
toward preventative and population health, as well as the shift in patient volume to 
ambulatory healthcare settings, requires new competencies in population-approaches, and 
skillsets such as population health management and predictive analytics (Love & Ayadi, 
2015). 
Summary 
This chapter reviewed the literature on managerial epidemiology, on DoI, the 
theoretical framework of this study, and on aspects of ambulatory healthcare leadership.  
The shift in focus from individual health to population health has influenced the shift of 
traditional management to a population-based model (Fos et al., 2018).  As the demand 
for this type of management continues to increase to achieve reduction in costs, improved 
access, and enhanced quality, the skills for using managerial epidemiology are imperative 
for managerial and organizational success (Fos et al., 2018).  As the increase in patient 
volume and the scope of ambulatory care continues to broaden, ambulatory healthcare 
leaders may require and rely on the use of managerial epidemiology more than other 
healthcare leaders.  These ambulatory healthcare leaders could be more challenged at 
improving cost, access, and quality than other healthcare leaders.  However, most 
healthcare leaders have not been educated on the practice as only a few undergraduate 
and graduate programs offer education on managerial epidemiology, (Caron & Hooker, 
2011).  Despite the literature emphasizing the engagement of leaders using managerial 
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epidemiology, there has been no further research exploring the diffusion of managerial 
epidemiology. In Chapter 3, I will discuss the research methodology, the research design, 
and the plan for data collection and analysis.   
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Chapter 3: Research Method 
Introduction 
The purpose of this study was to understand the perspectives of ambulatory 
healthcare leaders on the use and diffusion of managerial epidemiology.  In this study, I 
used traditional qualitative research using interviewing (see Ravitch & Carl, 2016).  
Understanding the leaders’ perspectives helped inform diffusion of managerial 
epidemiology to create improve organizational performance and ultimately, a healthier 
population.  In this chapter, I will share the research design, the role of the researcher, 
methodology, and issues of trustworthiness of the study. 
Research Design 
The design of this study was based on the research questions exploring 
managerial epidemiology and its diffusion.  The main research questions were as follows:  
Research Question 1: What are the perspectives and experiences of ambulatory 
healthcare leaders on the use of managerial epidemiology for decision-making?   
Research Question 2: What are the perspectives and experiences of ambulatory 
healthcare leaders regarding communicating the use of managerial epidemiology through 
the healthcare system? 
The key concepts explored through the study were managerial epidemiology and 
diffusion.  Managerial epidemiology is defined as the blend of epidemiology and 
healthcare administration (Fleming, 2013; Rohrer, 2013).  Diffusion is the way the 
innovation is spread with communication to individuals (Rogers, 2003).  Ibrahim (1983) 
described the concept of combining epidemiology with healthcare management to help 
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healthcare leaders make decisions based on population data to improve the health of great 
populations.  In addition, managerial epidemiology can assist in organizational 
performance for cost, access, and quality.  The diffusion of managerial epidemiology is 
not well understood, and the concept of managerial epidemiology for leaders is not seen 
extensively in literature.  As such, qualitative methods were most appropriate for this 
study.  To address the research questions, I used interviews to gather the perspectives of 
healthcare leaders in ambulatory settings.  Due to the newness of the concept of 
managerial epidemiology, the results of the practice could not be readily observed.  
Therefore, observability was not included in this study, but should be assessed as part of 
further research.  The remaining four elements of DoI were aligned throughout, 
including:  
Subquestion 1: What are the perspectives and experiences of healthcare leaders in 
ambulatory healthcare settings on the relative advantage of the use of managerial 
epidemiology? 
Subquestion 2: What are the perspectives and experiences of healthcare leaders in 
ambulatory healthcare settings on the compatibility of the use of managerial 
epidemiology? 
Subquestion 3: What are the leaders’ perspectives and experiences of healthcare 
leaders in ambulatory healthcare settings on the complexity of the use of managerial 
epidemiology? 
Subquestion 4: What are the perspectives and experiences of healthcare leaders in 
ambulatory healthcare settings on the trialability of the use of managerial epidemiology? 
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The interview guide included questions aligned to the research subquestions to better 
understand the diffusion of managerial epidemiology.   
Role of the Researcher 
My role as the researcher was to be a qualitative interviewer.  According to Rubin 
and Rubin (2012), a qualitative interviewer is someone who is curious and interviews to 
listen for meaning.  The qualitative researcher plans the interview with prepared 
questions as well as follow-up questions to uncover patterns (Rubin & Rubin, 2012). The 
role of the researcher is to interview participants and access the qualitative data to 
understand the perspectives of the participants (Sutton & Austin, 2015).  My role in 
organizing the study included recruiting the participants, conducting the interviews, 
organizing the data, and evaluating the results. 
The plan for recruitment of the participants involved ensuring that I did not have 
any relationships with the interviewees.  I purposefully planned to bypass any recruitment 
at previous institutions of employment as well as my current employer.  If recruitment 
proved to be challenging with these organizations excluded, I planned to recruit from my 
current employer, excluding the region where I was currently employed, to eliminate any 
relationship risks and reduce bias. Each individual region of my current employer has its 
own reporting structure and is considered a separate entity from other regions of the 
organization.  Therefore, I would not have existing experience, close relationships, or 
insider knowledge of these segments of the organization that would influence participant 
engagement or data analysis.  By purposefully excluding participants from my region to 
create this unknown environment would be an attempt to eliminate bias and uphold 
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validity of the data (Fleming, 2018).  Later in this chapter I will discuss approaches such 
as structured reflexivity and dialogic engagement that I used to manage my bias 
throughout this study. 
Methodology 
Participant Sampling 
In this qualitative study, the population included leaders at all levels with 
experience in ambulatory healthcare settings.  Ambulatory healthcare settings include 
primary care, specialty care, and ancillary services such as laboratory and imaging 
(Centers for Disease Control and Prevention, 2016).  For inclusion in the study, the 
participants needed experience in the qualified ambulatory setting of primary care, 
specialty care, or ancillary services, as well as have at least 1 year of leadership 
experience in an ambulatory setting.  Using the participant assessment tool, each 
participant was evaluated on these two criterion and notes were collected to explain the 
reasoning for participants being excluded from the study.  Purposeful sampling strategy 
was used to recruit participants for this study.  Purposeful sampling is important for 
building credibility and context (Ravitch & Carl, 2016).  Additionally, the research 
questions required purposeful sampling due to the focus of the research question on 
ambulatory health services leaders (van Rijnsoever, 2017).  Purposeful selection of these 
leaders enabled sharing of their perspectives on managerial epidemiology for contribution 
of answering the research question.   
Recruitment continued until I had interviewed at least 10 participants.  This was 
the minimum number of participants required to build credibility and provide robust 
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context.  According to van Rijnsoever (2017), saturation is reached when new codes or 
suggestions of new patterns are no longer seen in the data.  In this study, participants 
were recruited until saturation was reached.  Attaining saturation is particularly important 
when researching new concepts such as managerial epidemiology for healthcare leaders.   
Instrumentation 
A prepared interview guide was used for this study.  There are no published 
interview guides for managerial epidemiology, so I developed the interview guide myself 
using the components of DoI theory in the form of open-ended questions.  The interview 
tool was developed from the literature reviewed on healthcare leaders, managerial 
epidemiology, and DoI theory to inform the interview questions.  Additionally, the 
questions were focused on components of the DoI theory such as relative advantage, 
complexity, trialability, and compatibility.  The questions were clustered by these 
components.  To test for content validity, the instrument was pilot tested which includes 
vetting and rehearsing the instrument (Ravitch & Carl, 2016).  Piloting the instrument 
with the target sample population provided feedback for changes to the interview guide, 
research design, and process (Ravitch & Carl, 2016).  It also proactively identified 
problems with data collection and provided an opportunity to evaluate the alignment of 
data collected with the research questions (Ravitch & Carl, 2016).   
Data Collection 
To recruit participants, I used platforms including social network sites such as 
LinkedIn, affiliations such as university networks, email, in-person meetings, and phone 
calls.  Initial connections with potential participants were through referrals or 
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recommendations within my professional network.  The communication to participants 
included an introduction, reason for their targeted recruitment, notification of the 
requirement for completing my doctorate degree, purpose of the study, time 
commitments, overview of process, statement of confidentiality, my contact information, 
deadline for response, and expression of appreciation for their time.   
Once the participants contact me, I screened all participants using the participant 
assessment tool.  Participants were notified of their inclusion and next steps via phone, 
Skype or electronic messaging such as e-mail.  The notification of inclusion included 
information for next steps, such as scheduling the interview, interview logistics, the 
possible methods of interviewing, such as phone, in-person, or video calling, and a 
statement of appreciation for their time as well as commitment.  In this communication, I 
also provided the informed consent for their review and signature.  Participants who were 
excluded were also notified by phone, Skype, or electronic messaging.  Prior to the 
interview, at least one reminder was provided to the participant through email, phone, or 
in-person communication.  Recruiting participants and conducting interviews with vetted 
participants occurred simultaneously.  
A semistructured interview style was used to enable focused questions related to 
managerial epidemiology with the ability to ask follow-up questions (Rubin & Rubin, 
2012).  Interviews were conducted in person or virtually (i.e., via telephone or video 
technology) in a setting that was professional and convenient for the participant.  In-
person interviews were held in the participant’s work office or conference room.  Virtual 
interviews were conducted in a private, professional environment such as a conference 
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room.  The interviews were conducted for a total of 45-60 minutes.  I selected this time 
limit to encourage recruitment with minimal time commitment.  An introduction email to 
the study was sent ahead of the interview for the participant to become acquainted with 
the process and understand expectations.  In Appendix A, the detailed interview guide is 
presented.  The start of the interview included a first few minutes to introduce myself, 
revisit the introduction email, explain the process as well as next steps, confirm 
completion of the informed consent form, ensure the participant was comfortable, clarify 
definitions of key concepts, such as managerial epidemiology and population health, and 
encourage any questions from the participant before starting.  Background questions were 
gathered before conducting the specific interview questions in order to build rapport and 
learn more about the participant.  The data were recorded on my cell phone recording 
device or a LiveScribe recording pen.  The recordings were transcribed before the coding 
process started.  
Debrief and Follow-Up Procedures 
Each participant received an email noting my appreciation.  Included in the email 
was the transcript from their interview, providing the participant with the opportunity to 
review and share any additional remarks.  Follow up questions were explored as themes 
emerged, if information was missing, new or unanticipated ideas were uncovered, or if 
responses were ambiguous (Rubin & Rubin, 2012). Follow up questions would have been 
sent via email or asked through an in-person or virtual interview; however, no follow up 
questions were identified.   Once the study was complete, I sent another email of 
appreciation with the completed study. 
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Data Analysis 
I transcribed the interview recordings verbatim.  To start the data analysis, I began 
with precoding by reading through each interview transcript (Ravitch & Carl, 2016).  I 
used precoding to develop preliminary codes during the coding process.  Using words or 
phrases, I assigned labels as part of the inductive coding process to provide meaning to 
the data (Ravitch & Carl, 2016).  After precoding, open coding was conducted to 
determine initial meaning from the data (Ravitch & Carl, 2016).  Axial coding followed 
to identify patterns between the first-level codes (Ravitch & Carl, 2016).  Categories 
were developed from the identified themes (Ravitch & Carl, 2016).  A computer-assisted 
qualitative data analysis software was intended to be used to assist in organizing the data, 
but it was aborted after I determined it to be suboptimal for coding after the first attempt. 
Issues of Trustworthiness 
To address issues of trustworthiness, critical attention was given to credibility, 
transferability, dependability, and confirmability.  In this section, I will discuss each 
standard of validity and how it is upheld in this study.   
Credibility 
According to Cope (2014), credibility is described as the truth of the data and the 
researcher’s interpretation.  There are several strategies that can be used to support 
credibility including strategic sequencing of methods, participant validation, 
triangulation, thick description, dialogic engagement, multiple coding, and structured 
reflexivity (Ravitch & Carl, 2016).  Of these strategies, I employed the following 
strategies in this study: participant validation, strategic sequencing of methods, dialogic 
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engagement, and structured reflexivity practice.  By using strategic sequencing of 
methods, I helped build credibility through a research design that aims to improve 
contextualization of the data and handling of complexities of the study (Ravitch & Carl, 
2016).  According to Ravitch and Carl (2016), within-methods sequencing uses the 
participants’ perspective to design the flow of questions to improve the quality of data 
gathered (Ravitch & Carl, 2016).  This strategic sequencing strategy was applied by 
grouping questions by theme such as by elements of the DoI theory (Ravitch & Carl, 
2016). Participant validation strategy confirmed the interpretations of the interviewees 
were credible (Ravitch & Carl, 2016).  This strategy was executed by sharing the 
transcripts with the participant after their interview.  Dialogic engagement was used by 
requesting peers to review the research process and interpretations including the 
interview questions prior to conducting the interviews (Ravitch & Carl, 2016).  Lastly, 
practicing structured reflexivity was important for directing and self-reflecting on bias.  
This strategy requires the researcher to channel and challenge biases and interpretations 
outside through a structured approach such as journaling or mapping (Ravitch & Carl, 
2016).  For this study, I used a journal which included some mapping elements.  With 
these strategies executed, credibility was upheld throughout this study. 
Transferability 
Ravitch and Carl (2016) described transferability as the how the research is 
applicable to the audience and others.  The common strategies for transferability include 
a detailed description of the data and providing context for the audience (Ravitch & Carl, 
2016).  To ensure transferability in this study, I included a robust description of the 
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background and problem statement regarding managerial epidemiology to provide 
context for the audience (Ravitch & Carl, 2016).  The context also included definitions of 
the key concepts within the study such as population health, managerial epidemiology, 
and diffusion of innovation.   Using quotes from the interviews provided context for the 
findings and building trust in transferability. 
Dependability 
Dependability for qualitative research is defined as data stability (Ravitch & Carl, 
2016).  The stability of the data was upheld through alignment of the research methods 
and framework with the key concepts and research questions (Ravitch & Carl, 2016).  
This alignment was built into this study.  The theoretical framework of DoI was evident 
throughout the research questions.  Observability was purposefully excluded from the 
research questions due to the practice of managerial epidemiology being new and not 
widely used to be able to observe results.  Traditional qualitative method of was used 
because it was the most appropriate method for the research questions because the topic 
is not well known.  Since little is known about managerial epidemiology, other 
qualitative research methods were not suitable for the concept.  For example, grounded 
theory was not appropriate as the study is not exploring the development of a theory from 
the data regarding managerial epidemiology (Ravitch & Carl, 2016).  Ethnography was 
not selected as field studies would not be meaningful for this research as current literature 
is minimum and healthcare leaders are not trained in using managerial epidemiology; 
therefore, there was a risk of not finding enough data through an ethnographic approach 
(Ravitch & Carl, 2016).  Similarly, phenomenology presented a risk of not collecting 
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meaningful data as there is likely minimal lived experiences using managerial 
epidemiology (Ravitch & Carl, 2016). For these reasons, it was evident traditional 
qualitative research was the most appropriate method for this study.  This thorough 
alignment of the research design with the concepts and research questions supported 
dependability of the data collected. 
Confirmability 
Ravitch and Carl (2016) discussed the need for data to be confirmable.  For 
confirmability, it is necessary to identify bias and take proper measures to mitigate bias 
from penetrating the interpretation of the data (Ravitch & Carl, 2016).  The main strategy 
used was structured reflexivity with journaling and peer review which was discussed 
earlier in this section.  The interviews were recorded and transcribed which provided 
additional support for confirmability. I also encouraged and expected my dissertation 
committee to challenge my research process and thinking which included the oral 
defense. 
Summary 
In order to understand the perspectives of healthcare leaders in ambulatory 
settings on the use of managerial epidemiology, the qualitative research method of DoI 
was used.  In this section, the research method of using basic qualitative research 
methodology was described, as well as the role of the researcher, participant sampling, 
and issues of trustworthiness.  This chapter provided a comprehensive review of how the 
study was conducted, as well as justification of the research method selected.  
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Importantly, the critical steps for upholding trustworthiness were also explored.  In 
Chapter 4, I will discuss the results of this study. 
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Chapter 4: Results  
Introduction 
The purpose of the study was to understand the perspectives of ambulatory 
healthcare leaders on the use and diffusion of managerial epidemiology.  The two main 
research questions and subquestions were as follows: 
Research Question 1: What are the perspectives and experiences of ambulatory 
healthcare leaders on the use of managerial epidemiology for decision-making? 
Research Question 2: What are the perspectives and experiences of ambulatory 
healthcare leaders regarding communicating the use of managerial epidemiology through 
the healthcare system? 
Subquestion 1: What are the perspectives and experiences of healthcare leaders in 
ambulatory healthcare settings on the relative advantage of the use of managerial 
epidemiology? 
Subquestion 2: What are the perspectives and experiences of healthcare leaders in 
ambulatory healthcare settings on the compatibility of the use of managerial 
epidemiology? 
Subquestion 3: What are the leaders’ perspectives and experiences of healthcare 
leaders in ambulatory healthcare settings on the complexity of the use of managerial 
epidemiology? 
Subquestion 4: What are the perspectives and experiences of healthcare leaders in 
ambulatory healthcare settings on the trialability of the use of managerial epidemiology? 
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In Chapter 4, I provide an overview of the study used to explore these research 
questions. I will discuss the pilot study, setting, demographics, and data collection.  For 
an in-depth explanation of the study results, I will detail the analysis and its 
trustworthiness before closing the chapter. 
Research Tools 
Prior to the start of the study, I developed an interview guide to provide direction 
on the semi-structured interview process.  In Appendix A, the interview guide starts with 
questions to gather data about the participants.  For example, these questions allowed me 
to collect data on the participants’ education and leadership experience.  The remaining 
questions were targeted on managerial epidemiology including the diffusion and 
communication of the practice to address the two main research questions.  The interview 
guide was reviewed by the dissertation committee for feedback prior to Institutional 
Review Board (IRB) approval (06-11-19-0652278) and starting the study. 
Pilot Study 
Once IRB approval was received, I conducted the pilot study exactly as the formal 
study is outlined in the methods section.  Three participants were recruited using 
purposeful sampling.  The pilot study participants were identified through referrals from 
previous colleagues.  Email communication was used to introduce the study, assess that 
they met the inclusion criteria, gain their informed consent, and schedule the interviews.  
One of the participants did not meet the inclusion criteria and was excluded from the pilot 
study.  I conducted the pilot study interviews using the interview guide from Appendix A.  
The phone interviews were recorded on a password secure iPhone or computer.  Each 
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was transcribed verbatim from the recordings and manually coded using open coding.  
The transcripts were provided to the participants for review in follow-up thank you 
emails.  No revisions or additions were received from the participants. 
The pilot study transcripts were reviewed by my dissertation chair.  After the 
review of the transcripts, a meeting was held to discuss the interview questions, process, 
and next steps.  The data appeared to be deep and aligned with the research questions.  
The end-to-end process for recruitment, interviewing, and providing the transcript to 
participants proved to be effective and well-designed.  No changes were made to the 
main study design including the interview questions.  The data from the pilot study were 
therefore included in the main study. 
Data Collection 
Participants were mostly obtained through referrals from my own personal and 
professional networks. Social media posts were used on sites such as LinkedIn; however, 
direct messaging was more effective.  Purposeful sampling was used to recruit 
participants and included any healthcare leaders with experience in ambulatory healthcare 
settings.  The leaders needed to have at least 1 year of ambulatory care leadership 
experience.  For the purpose of this study, the acceptable ambulatory settings included 
primary care, specialty care, and ancillary services.  Recruitment continued until a 
minimum of 10 participants were identified as outlined in the study methods.  Due to 
challenges with recruiting the number of participants needed to reach data saturation, I 
expanded recruitment to previous employer organizations. This was a deviation from the 
data collection plan outlined in Chapter 3; however, to mitigate relationship bias I 
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recruited from organizations I had left more than 3 years ago.  Including the two 
participants from the pilot study, a total of 14 participants were identified for 
participation in the study. One participant cancelled their interview and did not 
reschedule due to personal circumstances.  Another participant never scheduled an 
interview despite multiple outreaches.  In addition to the two participants from the pilot 
study, another 10 participants were included in this study for a total of 12 participants. 
Once participants were identified as meeting the inclusion criteria using the 
participant assessment tool, I provided additional context about the study.  The consent 
form provided additional context and was shared for review through email 
communication.  The scheduling process was largely contingent on the participants 
availability.  Most participants scheduled their own interview while others requested 
assistance from their administrative assistant.  Once participants consented and 
interviews were scheduled through email, the interviews commenced.  Due to holiday 
travel to the same location of two of the participants, their interviews were scheduled for 
in-person meetings.  The remaining 10 interviews, including the pilot study, were 
conducted by telephone.  
To start the interviews, each participant was provided an overview of the 
interview process and encouraged to ask questions.  Before starting the interview, I 
addressed any questions the participants had about their engagement in the study and 
asked if there were any questions about the consent form.  There were never questions 
about the consent form, which had been reviewed and returned to me via email prior to 
the interview.  Additionally, uncommon terms were defined at least once before the 
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interview started and often again during the interview especially the term managerial 
epidemiology.  I asked permission before starting the interview to record the interaction.  
I closed every interview by expressing my gratitude for their engagement.  After the 
interview was complete, I transcribed all recordings in Microsoft Word.  The transcripts 
were sent to each participant for validation as part of a thank you follow-up email.  
Participants were asked for feedback on the transcripts including any additions or 
revisions.  However, no feedback was received on any transcript. 
Setting 
There were no personal or organizational conditions to report for this study.  Two 
interviews were conducted in person in participants’ professional offices with the door 
closed for privacy.  The majority of the interviews were conducted via telephone.  The 
phone interviews were completed from my personal space or a secluded conference room 
for privacy.  I always communicated the privacy of my location for the interviews. .The 
settings where  the participants engaged in the phone interviews varied.  Of note, some 
were in their work offices while a couple were completed during their work commute.   
Data Analysis 
I attempted to use a computer-assisted analysis software called NVivo with one 
transcript in the pilot study and discovered it to be suboptimal for use because of the 
steep technology learning curve, cumbersome process for assigning codes, and 
challenging visual representation of data analysis.  All interview data were stored and 
manually analyzed using Microsoft Excel.  To start data analysis, I read all transcripts 
and used precoding by assigning labels to begin developing meaning (Ravitch & Carl, 
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2016).  After precoding was complete, I used visual mapping of first-level codes to 
identify patterns (Ravitch & Carl, 2016).  Once patterns were discovered, categories were 
outlined, and themes were deduced.  An example of the data analysis progression from 
codes to categories and finally theme is provided in Table 1. 
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Table 1 
 
Data Analysis for Theme 4: Current Level of Adoption is Variable 
Participant 
number 
Data Code Category Theme 
4 Right now, our current practices don’t even focus 
on managerial epidemiology. So, that’s how it is 
misaligned-there’s no connect right now. 
ME not adopted. Current 
Adoption 
Current level of 
adoption is variable 
4 Right, it is currently not used here yet. ME not adopted. Current 
Adoption 
Current level of 
adoption is variable 
5 Um, can you define a little bit better on the 
managerial epidemiology term. That’s not a term 
that I’ve used…Maybe we do use it more here or 
equivalently, but I don’t think so. Maybe we do 
use it more here or equivalently, but I don’t think 
so. 
org not using 
ME, currently 
Current 
Adoption 
Current level of 
adoption is variable 
11 Where I am just with people who are at least 
attempting to think outside of the box, to think of 
different solutions to different problems. None I 
mean One conference touches a little bit of this. 
The other conferences do not touch it at all. 
Not well 
adopted in 
educational 
settings like 
conferences. 
Current 
Adoption 
Current level of 
adoption is variable 
11 I think so— seeing it more and more that’s for 
sure. [ME in op plan process] 
Starting to see 
adoption in 
operating 
planning process 
Current 
Adoption 
Current level of 
adoption is variable 
1 I would think it is very much integrated. I don’t 
think we use that term today. But, I think that is -- 
We have formed complete separate divisions in 
the health system get good at that so we can make 
good decisions and we can be effective managers. 
… 
Integrated Current 
Adoption 
Current level of 
adoption is variable 
3 So, for managerial epidemiology. you know-- I 
think a lot of people do this but they just don’t 
call it that.” 
Using, but do 
not know term 
Current 
Adoption 
current level of 
adoption is variable 
10 I might not be the right guy to ask, I live and 
breathe it. I mean, the organization might not be 
ready for it or the term. 
Individual using 
ME, but not 
organization 
Current 
Adoption 
Current level of 
adoption is variable 
9 I think it has to happen. I think it does happen. I 
think sometimes it happens more purposefully 
than others. I think sometimes people are more 
aware of it than some. Some by default, back into 
it, but they get there. 
Using by 
accident; not 
part of process 
Current 
Adoption 
Current level of 
adoption is variable 
12 I definitely have colleagues who take more of a 
hands-off approach to the data—they look at all 
of the top-line data and they look at the 
productivity for their physicians and throughput 
for their patients, but they don’t do a deep dive to 
discover… 
Not using. 
Superficial use 
of data analysis 
Current 
Adoption 
Current level of 
adoption is variable 
Note. Data displayed are direct quotes from participants. ME = managerial epidemiology. 
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Research Findings 
In this section, I will first share demographic data to provide a general 
background of the participants.  The remainder of this section is organized by study 
findings for each theme.  Each theme will be discussed in-depth and align back to the two 
main research questions. 
Demographics 
Twelve leaders met the participant criteria and were interviewed.  The participants 
were all working in healthcare organizations in the United States.  The study captured 
data from healthcare systems in all regions of the United States.  The locations of their 
current employer provided representation for the Northeast, Northwest, Southern, and 
Midwestern parts of the United States. The sample included a mix of male and female 
ambulatory healthcare leaders.  Of the 12 participants, there were five male participants 
and seven female participants.  Some leaders also had current or previous clinical 
experience, for example, as a midlevel practitioner, physician, nurse, or phlebotomist. 
In Table 2, I provide an overview of the participants’ demographics including 
years of experience, education, and clinical background. All participants had at least 2 
years of ambulatory leadership experience; however, the sampling was well 
representative including up to 45 years of experience and a calculated median of 11 
years.  The ambulatory setting experience of the participants was vast.  Some 
participants’ current oversight spanned across all ambulatory services, whereas others 
had focused oversight of a single department such as oncology.  Of note, two participants 
worked the majority of their careers solely in oncology. Commonly, participants shared 
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that their experience in ambulatory settings grew or changed over their career 
progression.  For example, one participant had laboratory operations management 
experience and now has responsibilities in an oncology setting.  Another participant’s 
experience encompassed a significant variety of ambulatory settings such as 
otolaryngology and neurosciences among others but stopped listing examples because 
“the list can go on and on, but that’s probably a good smattering.”   
Participants achieved a minimum of a bachelor’s degree and some held a doctoral 
degree.  More than half of the participants (58%) held a master’s degree as their highest 
level of education.  Seventy-one percent of the master’s educated leaders specialized in 
healthcare administration-related degrees.  Four participants or 33% of participants held a 
doctoral degree including a Doctor of Philosophy or Doctor of Medicine.  It is notable to 
mention that one participant with a Doctor of Medicine degree completed a dual program 
for a Master’s in Business Administration as well.  I characterized all participants as 
altruistic based on their description of their journey into healthcare leadership and how 
they remain energized and engaged.  Specifically, their responses described the desire to 
impact patients or the greater population, and frequently responses mentioned the people 
or mission at their organization were energizers. 
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Table 2 
 
Participant Demographics 
Participant 
number Highest level of education 
Ambulatory 
experience 
Clinical 
experience 
(Y or N) 
1 Master’s degree in Business Administration 7 years N 
2 Master’s degree in Healthcare Administration 3 years N 
3 Master’s degree in Health Systems Management 12 years Y 
4 PhD in Nursing 10 years Y 
5 Master’s degree in Healthcare Administration  14 years N 
6 Master’s degree in Nursing  2.5 years Y 
7 Master’s degree in Healthcare Administration 16 years N 
8 Bachelor’s degree in Community and Health Sciences 28 years N 
9 PhD in Adult & Higher Education 45 years Y 
10 Doctor of Medicine 30 years Y 
11 Doctor of Medicine 5 years Y 
12 Master’s degree in Healthcare Administration 2 years N 
Note. To display if the participants have clinical experience, Y = Yes and N = No. 
 
Themes 
Initially, pattern analysis of all codes developed multiple categories.  These 
categories were assessed for commonalities and differences.  Themes emerged quickly 
and were aligned with the two research questions: 
Research Question 1:  What are the perspectives and experiences of ambulatory 
healthcare leaders on the use of managerial epidemiology for decision-making? 
Research Question 2: What are the perspectives and experiences of ambulatory 
healthcare leaders regarding communicating the use of managerial epidemiology through 
the healthcare system? 
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In this section, I organized each theme under the aligned research question.  I 
discuss the themes thoroughly and the linkage to the research question. 
Research Question 1 
For the first research question, I sought to understand the perspectives and 
experiences of ambulatory leaders on the use of managerial epidemiology for decision 
making.  To do so, I asked interview questions such as “How would the use of 
managerial epidemiology be an advantage to ambulatory healthcare leaders?”  Four 
themes were identified for the first research question. 
Managerial Epidemiology Is Critical and Has No Disadvantages 
When asking participants about the benefits of managerial epidemiology and 
compatibility, participants were emphatic in their responses.  As I listened to their 
responses to my question, they sounded incredulous, implying, “why would you even ask 
such a question?” or “isn’t the answer evident?”  Eighty-three percent of participants 
responses were statements that managerial epidemiology is critical.  When discussing the 
essential nature and importance of managerial epidemiology, the participants were 
emphatic in their responses by using words or phrases that expressed conviction.  
Participant 10 used a definitive tone when stating, it did not matter “whether or not its 
compatible or not, it is necessary.”  I interpreted this response as meaning that the 
practice is needed regardless of any potential barriers to using it.  Participant 9 responded 
similarly to Participant 10 by stating, “Well, honestly- I think it is essential.”  Participant 
12 used expressive language in stating, “I think that the use of managerial epidemiology 
is paramount to ambulatory leaders”.  Participants elaborated on the essential nature of 
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the practice of managerial epidemiology such as Participant 4 stating, “Well, I think what 
it would do for the mangers is help understand their population which I think is critical 
and we don’t do a good job at that.”  Similarly, Participant 5 explained, “I think we need 
to be more focused on that [managerial epidemiology] as we continue to move to the 
future.  I don’t see how you can ignore it.” 
Most participants stated there are no disadvantages with using managerial 
epidemiology.  The participant responses were direct and short such as “I don’t see a lot 
of disadvantages to applying that practice” from Participant 9 or “You know, I don’t have 
a good answer for that” from Participant 8. Participant 4 stated, “In my head, I don’t see a 
disadvantage”.  Three participants responded with challenges to adoption of managerial 
epidemiology rather than a disadvantage.  For example, Participant 3 noted that there is a 
lack of awareness by senior leaders for the need of a data personnel to support managerial 
epidemiology and thereby, the funding may not be available.  Participant 2 answered that 
adoption is generally slow for new things and gave recommendations for increasing the 
rate of adoption of managerial epidemiology. Uniquely, Participant 7 discussed the 
challenge of data integrity as well as unconscious bias of the leader or analyst that could 
inadvertently miss capturing populations or variables of populations in the reporting or 
analysis.   
Managerial Epidemiology Provides Objectivity and Supports Transformation 
Participants discussed the main advantage of managerial epidemiology is the 
ability to bring objectivity and focus to leadership functions especially decision-making.  
The participants shared that without managerial epidemiology, decisions are often made 
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based on individual or limited experiences, emotion or assumptions, and a piece of the 
puzzle without seeing the bigger picture.  Ultimately, participants believed managerial 
epidemiology equips leaders to make more focused and better decisions.  In this section, I 
share participant responses on how managerial epidemiology brings objectivity and how 
it supports healthcare transformation.   
Eighty three percent of participants referred to gaining objectivity as a benefit of 
using managerial epidemiology.  I noticed the topic of objectivity woven through 
interview responses frequently.   
Participant 11 stated, “you only know what you experience and none of us 
experience everything” to describe the benefit of objectivity through using managerial 
epidemiology.  This participant went on to describe that a wider viewpoint provided by 
managerial epidemiology can have an impact on greater patient populations by stating,  
[Managerial epidemiology] is helpful for people to see the high level.  If we look 
at our patients as a whole thirty-thousand patients and not just the 10, 20, 30 
patients that I am going to see today.  This is what we are doing as a whole, not 
just impacting 1:1 care.  
Managerial epidemiology provides a broad, systems thinking view as Participant 11 
described and a focused vantage point as described by Participant 9: 
It [managerial epidemiology] keeps you focused and helps your decision making.  
It is very easy to be bombarded with a lot of information, a lot of requests, a lot of 
need.  It helps to provide a focus and sometimes it can be narrowly defined and 
sometimes it can be very broad.   
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To elaborate on the focus provided by managerial epidemiology, Participant 2 described, 
“I think it could also support a number of different initiatives that ambulatory leaders are 
grappling with.”  From this discussion, it is evident that the objectivity from managerial 
epidemiology can help ambulatory health services leaders with workload management. 
Further, Participant 12 shared the benefit of managerial epidemiology for 
decision-making on clinical outcomes: 
Having that data will give better clinical outcomes because you are able to—you 
would have the data backing up your decision; whereas, I mean- a lot of people 
like to make decisions that don’t have any information backing them up. Having 
some of that data would lead to better choices for our patients and hopefully, end 
up with better patient care as a result. 
This elaboration on the benefits of managerial epidemiology suggested leadership 
decisions informed through managerial epidemiology can impact clinical outcomes for 
patients. 
Conversely, Participant 12 described what decision-making is like without 
managerial epidemiology by stating, “I feel like it would be a hit or miss approach and it 
would go back to really what has been done in the past--where it is the physicians’ gut 
feeling.”  In that same vein, Participant 4 shared that managerial epidemiology “narrows 
down to very patient-centric things and moves away from provider focused, but more 
patient-focused.”  Participant 1 shared a similar perspective, “I would think that it would 
be used in almost every aspect.  I mean really, not having it basically you’d be shooting 
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in the wind.  You would have to have it.”  Participant 5 described the benefit of 
managerial epidemiology providing objectivity in decision-making by noting,  
I’ve had people tell me things that they just assumed… It slows things down but 
it’s important to try to understand [managerial epidemiology] because your 
assumptions can often be wrong.   
While managerial epidemiology might slow the pace of decision-making, the benefits of 
improved identification of problems and informed decisions are valuable as Participant 8 
shared,  
And like I said, there’s a lot of times it is just you know—we tend to have…I 
don’t want to call it like knee jerk reactions, but more emotional responses to 
things going on in the clinic and emotional responses in trying to lead different 
things and go with it instead of taking more of a really complex, analytical 
approach to decide where our problems are and what we can do to mitigate that. 
As I listened to the response of Participant 8, I interpreted that incorporating managerial 
epidemiology could provide objectivity for an ambulatory healthcare leader as they make 
decisions that are sometimes emotionally charged and challenging.  
Interestingly, the two participants who did not explicitly discuss objectivity were 
the participants who already use managerial epidemiology in their organizations.  I 
suspect objectivity is already hardwired with the use of managerial epidemiology in their 
decision-making process; therefore, they are not experiencing the lack of objectivity as 
much as other participants. 
51 
 
From the responses, it is evident that most decisions made by ambulatory leaders 
are not informed by the existing data that could provide a better understanding of the 
populations they serve.  Despite this, participants went on to describe that the objectivity 
from managerial epidemiology could support various healthcare transformation efforts.  
Healthcare transformation was discussed frequently in the interviews.  It is evident that 
managerial epidemiology is a catalyst for healthcare transformation.  Participants 
described the use of managerial epidemiology to support healthcare transformation in a 
few ways including: the shift of patient volume towards ambulatory settings from 
hospital settings, value-based care, population health, and physician shortages.  Multiple 
participants discussed the transformation of shifting patients from the hospital settings to 
ambulatory settings.  Participant 6 expressed the importance of the ambulatory setting 
and heightened awareness of shifting patient volumes to this division of healthcare 
organizations by stating, “The ambulatory setting is really what is driving healthcare. We 
want to shift the focus to the outpatient, not the inpatient.”  Participant 3 elaborated on 
using managerial epidemiology can provide necessary information to determine how to 
shift patient volumes  
It should be every hospital that has an outpatient setting, every health system that 
has an ambulatory division should be paramount to ensuring the healthy bottom 
line.  I mean, inpatients are expensive.  They are rarely reimbursed at the rate that 
you hope to be.  Your procedural lists tend to make up that via your surgeons or 
anybody invasive to a patient. So, in order to have a healthy bottom line, you 
really need ambulatory process to see patients who don’t really need admissions 
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anyway.  So, to me- if you have a healthy data set that allows you to make 
clinically sound decisions that way you are not discharging someone home that 
really does need to be admitted or coming up with a hospital at home model or 
72-hour stay model where they are not admitted, but they’re in the ambulatory 
setting. These are good ways of controlling costs.  So, you know, those analytics 
and that discipline [managerial epidemiology] would allow to make good 
objective decisions.  For example, you know- one of the things you look at a 
cancer center is emergency room visits during business hours of the cancer center.  
They would just come here [ambulatory cancer center] as they should and not 
clog up the emergency room.  This seems like a simple report that you pull down 
and figure out ED volumes and attach them to active chemo or treatment. 
From the response and examples provided by Participant 3, financial performance of the 
healthcare organization is dependent on shifting patients from higher cost settings such as 
hospital settings to lower cost settings such as ambulatory setting and can be supported 
by managerial epidemiology. 
Unfortunately, the healthcare financial challenges exert pressure on shifting 
patient volumes to ambulatory settings. This pressure is compounded by an industry 
physician shortage as described with urgency by Participant 6, “There aren’t physicians 
running into primary care anymore”.  Later in the interview, Participant 6 shared an 
example of how managerial epidemiology is used to allocate mid-level practitioners 
based on the physician shortage to assure that population needs are matched. Not only 
can managerial epidemiology be utilized for identifying the patients appropriate for 
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ambulatory settings but can also be used by ambulatory care leaders to be better prepared 
for an influx of patient volume by planning allocation of healthcare provider resources. 
Additionally, participants discussed managerial epidemiology benefiting the 
transformation to value-based care.  Thirty-three percent of participants used the exact 
term, “value-based care” or described the evolution of healthcare models from quantity to 
quality.  A failure of our current state of traditional healthcare was described by 
Participant 11, 
1:1 patient interactions… There is like this an art of medicine that to me, I think is 
over-used and used to compensate for us doing nothing like in any organized way.  
So, I think with what is being demanded of healthcare with the changes, it 
[managerial epidemiology] will actually align both [art of medicine and value-
based care].  
In response to our failing traditional healthcare system, Participant 6 expressed the 
emerging model of value-based care, “I think we are just now starting to turn the corner 
where we are looking more at quality over quantity.”  This response sounded warm and 
slightly higher pitched which I interpreted as hopeful.  To turn the corner to value-based 
care, Participant 2 shared the utility of managerial epidemiology, “I think it [managerial 
epidemiology] obviously supports this cultural shift from volume to value.”  Government 
programs incentivize the healthcare system to transform and managerial epidemiology 
can help identify participation in these programs Participant 1 elaborated,   
Last example [for using managerial epidemiology] might be-- which government 
programs to participate in.  There are a number out there that challenge hospitals 
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to act in a more value-based way. We go through a lot of analytical functions to 
see which ones we would like to play in and which we would not like to play in. 
The benefit of such value-based contracting was thoroughly explained by Participant 10 
who discussed,  
So, we contract with companies/entities that are providing healthcare to a group 
of people and then monitor the way that they are spending money on individual 
patients.  Then, we engage the physicians to help us manage the cost and improve 
clinical outcomes.  So, if we save money, we can share savings with the 
physicians involved. 
As exemplified by participants’ responses, it is clear that our healthcare system is being 
transformed into a value-based care model, the government is supporting this change 
through value-based contracting incentives, and managerial epidemiology can support 
this transition to the new healthcare model. 
As it relates to value-based care, Participant 2 noted value-based care and 
population health are often used interchangeably.  Participant 2 continued to discuss the 
inconsistency in defining population health and the importance of developing a common 
definition and language.  Importantly, it was clear that all participants were describing 
population health as understanding and managing the populations they serve to achieve 
improved organizational performance especially financial performance.  Participant 2 
shared, 
Basically, we agreed to a population health management definition.  Basically, the 
design, delivery, & coordination of high value healthcare services to manage the 
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quadruple aim: Population health, patient experience, cost, and joy in work for 
populations using the best resources we have available to us within the healthcare 
system. 
This definition provided by Participant 2 is congruent with how the participants described 
population health.  
Interestingly, the participants readily assumed managerial epidemiology was 
associated with population health.  Without prompting, and prior to the population health 
interview questions, participants frequently discussed population health on their own 
when talking about managerial epidemiology. This validated that it was appropriate to 
include interview questions on population health. Based on minimal literature of 
managerial epidemiology being used by ambulatory healthcare leaders for the emerging 
priority of population health, the questions on population health were last on the 
interview guide (see Appendix A).  Directly or indirectly, all participants expressed the 
use of managerial epidemiology as beneficial and supportive of population health.  For 
example, a common code presented throughout the data was examples of using 
managerial epidemiology for population segmentation. 
Early in the interview, Participant 5 was asked how managerial epidemiology 
might be misaligned with current norms.  Participant 5 responded,  
I don’t see that it is misaligned.  I think we need to be more focused on that 
[managerial epidemiology] as we continue to move to the future.  I don’t see how 
you can ignore it.  Yeah, we need that especially as we move to population health.  
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I think the fact that we don’t have it everywhere—like we’re not…managerial 
decisions are not necessarily based off of information that they should be. 
From this response, it is clear Participant 5 readily associated managerial epidemiology 
with population health prior to the specific population health questions were asked. 
 Participants 9 and 12 discussed the benefits of managerial epidemiology for 
population health.  Participant 9 elaborated,  
First of all, you really have to understand the population you’re serving.  And the 
population is going to be a diverse population. So, you need to understand about 
that diversity and it’s going to be diverse in so many ways.  We can talk about 
socioeconomic, racial diversity, and certainly within the difference diseases that 
you see.  What is exciting now- is the attention that is being given to the Social 
Determinants of Health. And while you need to understand your population, you 
also need to understand your organization and organizational resources. 
Participant 12 stated,  
And I think population health level seeing what patients are—what patients; for 
lack of a better way of saying it, cost the most—and seeing what we can do to 
work on that and improve not only their health but reduce the amount of cost 
associated with their health.  I think managerial epidemiology has huge potential 
to benefit things like that. 
These participants highlighted the benefits of using managerial epidemiology to 
understand the population and their needs especially for patient populations for whom 
healthcare is costly. 
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Despite the acknowledgement by participants that managerial epidemiology is 
critical for ambulatory healthcare leaders and would provide an understanding of their 
patient population and the population’s needs for better decision-making, two participants 
expressed the view that population health was not in their responsibility.  Participant 3 
stated,  
I am focused on what I am focused on and has very little to do with population 
health because that’s not my role. But someone two levels above me could be 
saying yeah, but we need to put all these physicians in this market because they 
would control admissions. Then, when it gets to me, I’ll get the why and I’ll 
recruit the physicians, hire them, and deploy them.  It’s very situational.   
Participant 4 explained,  
We have a population health expert.  We have a couple in the department and are 
mostly focused on research agenda. There are meaningful use criteria that will 
play a role in that somehow.  It doesn’t relate to my role as an operational 
administrator here. 
Participants 4, 6, and 8 described newly hired personnel are dedicated to population 
health strategy.  Participant 4 shared,  
Right now, we hired a Chief of Strategy & Population Health.  She has probably 
been here about 3 months now. She is building a whole population health team. 
Participant 8 stated,  
We have a population health expert.  We have a couple in the department and are 
mostly focused on research agenda. 
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The noted contradiction of leaders’ responsibility in population health as well as the 
recognition of newly hired population health leaders, suggested that the emerging concept 
of population health is starting to be adopted, but not yet widely integrated.   
To elaborate on the adoption of population health, participants such as Participant 
10 and 12 mention discussed some reasoning behind the recent uptick in adoption. 
Participant 10 shared, 
And frankly, the fact that population health is coming to the fore—I’ve been in 
the space for 30 years. And now people seem to care about it.  I was pretty sure, I 
was going to die before people starting to care about it.  But now people are 
starting to pay attention. So, now people are starting to care about population 
health because there is so much money for gain or loss. 
Participant 12 stated,  
And I think, population health level seeing what patients are—what patients for 
lack of a better way of saying it, cost the most—and seeing what we can do to 
work on that and improve not only their health, but reduce the amount of cost 
associated with their health. 
Interestingly, both participants discussed a reason for population health being adopted is 
due to the financial benefits such as cost savings or incentives to the organization.   
Additionally, it appeared the current awareness around population health is 
revolving around social determinants of health and care management.  Commonly, social 
determinants of health were described as a key part of population health strategy and the 
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need to use population data to look at the whole picture and whole person, as described 
by Participants 2, 6 and 9.  Participant 2 discussed,  
I would say that often times whether good, bad, or indifferent, decisions are 
sometimes driven by things other than incorporating pop health data -- I think 
they are looking at financials or one siloed piece of the organization instead of the 
whole picture.   
Participant 6 shared,  
So, I think if you look at what’s surrounding the ambulatory setting you know, 
demographically—what’s our population, what’s the average age, race, gender, 
socio-economic status.  And making sure that not only those patients have access 
to you, but do we have the resources to help them…You know, reminding people 
that you are not just there to click off some boxes, you know prescribe medication 
and then go about your day.  There’s a whole patient there that we need to be 
looking at and treating. 
Furthermore, Participant 9 explained,  
Again, I think it is because the embracing social determinants of health.  And 
understanding where that fits in with the organization.  It is creating a positive 
change in that direction.   
While the current focus and awareness for population health is on social determinants of 
health, it is giving momentum for using managerial epidemiology and a broader 
population health view throughout a healthcare organization. 
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The examples of healthcare transformation given by participants such as shifting 
patient volume to ambulatory settings and value-based care were describing tactics or 
action plans of shifting our healthcare system towards a population health approach.  In 
other words, the examples of shifting patient volume to ambulatory settings, resource 
allocation to address physician shortages, and development of a value base care model 
were all describing drivers of healthcare transformation and the healthcare transformation 
is interpreted as transforming our healthcare system into a population health approach.  It 
is evident that managerial epidemiology can be used as a tool for this transformation of 
the healthcare system.  To elaborate, shifting patient volume from hospital settings to 
ambulatory settings is a byproduct and key tactic of implementing value-based care 
models which can be supported by managerial epidemiology.  The physician shortage 
described can be considered a barrier for achieving value-based care models and the 
transformation to a population health approach; however, this roadblock can be resolved 
through using managerial epidemiology for resource allocation.  Additionally, value-
based care models and contracts are methods driving the transformation to a population 
health focused healthcare organization and can be supported by managerial 
epidemiology.  Lastly, the interchangeable nature of value-based care and population 
health as well as the definition of population health demonstrated an interlinkage of these 
use cases as well validation of the interpretation for healthcare transformation as being a 
transformation of our healthcare system to a population health approach.  
In summary, this second theme provides insight on why managerial epidemiology 
is considered critical by outlining the benefit of objectivity and the utilization of 
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managerial epidemiology for healthcare transformation, which is population health.  It 
appeared value-based care, shifting patient volumes, and resolving physician capacity 
challenges are pieces of the transformation to population health.  Fortunately, managerial 
epidemiology can support all these components.  The spread of population health strategy 
is underway and incorporating a heavy focus on social determinants of health currently 
but will spur momentum for adopting managerial epidemiology and population health 
more broadly.  Despite ambulatory health services leaders’ acknowledgment for the use 
and benefits of managerial epidemiology and for healthcare transformation, an awareness 
for ambulatory health services leaders’ role in population health is needed.  
Managerial Epidemiology Can Impact Triple Aim for Overall System Performance 
The use of managerial epidemiology and integration of population health strategy 
were both described to impact the overall system performance and triple aim.  These 
terms were often used fluidly.  In fact, Participant 10 expressed the fluidity, 
I mean the phrase, I have been in this field for forever, but I’ve never heard the 
phrase before… but I get what it is.  So, you’ll have to explain it.  But managerial 
epidemiology could be population health, finance, outcomes or triple aim. Triple 
aim, you know what that is right?  So, I use that a lot. You know, I use that phrase 
a lot. Everyone understands that! 
To tease this apart further, it appears managerial epidemiology is a tool for population 
health strategy which impacts overall system performance through improvement of the 
triple aim.   
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Additionally, the metrics and goals of healthcare organizations and healthcare 
leaders were linked to the triple aim such as reducing total cost like total cost per member 
per month (PMPM), reducing hospital admissions and emergency department utilization, 
improving patient satisfaction, and improving quality metrics such as those set by the 
government or payers.  Interestingly, many of the examples for managerial epidemiology 
described by the participants were aligned with the organization and healthcare leaders’ 
goals for impacting the triple aim.  Participant 2 exclaimed,  
I mean, I think so [managerial epidemiology impacting triple aim].  It seems like 
it would be hard not to, if you are incorporating the use of population health data 
and epidemiology into practice, how could it not that have some impact and 
understanding and help us to make decisions whether that is resource allocation? 
Programmatically, that [managerial epidemiology] could really help us move 
forward. 
Participant 2 emphasized the clear impact managerial epidemiology could have on the 
triple aim and the progress of the organization.  Some participants expressed current use 
or future interest in using managerial epidemiology for strategic planning, operating plans 
and goal cascade processes as Participant 10 described, 
I think for some, it has become more of an action plan.  It is something that the 
CEO is made aware of—so generally what I call the goal congruencies.  So, if the 
CEO is being held to standard around population health, then he/she will hold 
their [teams] to some similar standard so that the goals of the organization are 
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congruent up and down the organization at every level from the senior people 
then all the way down to primary care offices. 
Similarly, Participant 2 explained,  
Yeah, I think so. [Managerial epidemiology could be helpful for strategic 
planning] And I think the epidemiology piece really speaks to kind of the 
clinician’s heart which is obviously our audience especially in academics—
there’s more of that lens.  So, I think it would be a really interesting tool to use to 
kinda drill down and determine where we want to go. 
Interestingly, Participant 12 noted,  
I think that not that it [managerial epidemiology] is misaligned with leadership, I 
think that leadership is misaligned with the available tools to create a high-quality 
healthcare system. 
It is clear that the friction between the use of managerial epidemiology and traditional 
leadership styles can hinder realization of an improved healthcare system.  I interpreted 
the response from Participant 12 as leaders need to adapt their leadership styles to align 
with the practice. 
A key takeaway is the more a leader can know about their patients and patient 
population, the better and more focused the decision-making will be for impact on the 
organizational performance, leadership goals, and ultimately the triple aim.  Of the three 
triple aim components, participants resounded with heightened awareness of financial 
constraints and incentives on the healthcare system which is driving the need for 
improved performance particularly financially.  Participants provided examples of many 
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managerial epidemiology cases for improved financial performance and the need to use 
managerial epidemiology in financial decision-making.  Participant 2 shared, 
Often times, we are looking at different populations where we are financially at 
risk or where patients have a narrow network…As we transition [to value-based 
care], we’re trying to understand if I take on a patient population of 10k new 
Medicaid lives and they’re incredibly ill, how can I use that information that we 
know clinically to translate that into proactively hiring resources to best care for 
those patients and achieve the quad aim… The norm is shifting and becoming 
much more common regular claims-based feedback that are looking at different 
specific populations, we’re stratifying consistently- so, we are segmenting 
different populations.  So, I would say yes—we are definitely swinging in that 
direction [to using population data and managerial epidemiology in financial 
performance].   
Additionally, Participant 7 elaborated, 
Yeah, yeah- so a lot of financial incentives right as most folks have. So, in [state], 
we are in this total cost of care approach. So, you know, our hospital with the 30-
day readmission rate, we are penalized if we go over a certain amount. You know, 
the patients that are going into the hospital contributing to the total cost of care, 
we want to make sure they are utilizing the right resources in the right way at the 
right time. A lot of this—there are a lot of financial incentives for managing 
outcomes, access, and utilization. 
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As described by Participants 2 and 7, financial incentives and improved financial 
performance are motivators for impacting triple aim such as incentives tied to reduced 
utilization or controlling access and managing particular patient populations.   
Overall, participants believed managerial epidemiology could be used for 
managing patient populations to impact the triple aim.  Many practical applications of 
using managerial epidemiology were discussed by participants.  Participant 1 described 
an application by discussing, 
We utilize you know, big data a lot to provide access. So, you know- where our 
patient population lives, works, the items that they needs, the access they may 
need is a big-obviously, the main focus of when we decide where we deploy 
services whether it is more primary care practices or specialty care related… My 
group uses big data and financial performance within our health plan which is a 
10k lives health plan to also discover which prime conditions are most prevalent, 
most costly, most effectively improved through case management programs. 
The managerial epidemiology application shared by Participant 1 detailed use of the 
practice for case management programs as part of population health efforts for improving 
access and reducing costs.  Another example is quoted by Participant 8.  Participant 8 
explained,  
Well, I think it [managerial epidemiology] obviously is useful to determine what 
is needed to improve the patient experience.  Obviously, not so much directly 
related to my job, but improving health outcomes.  So, like the example of 
monitoring for falls, how many times do patients fall on an inpatient unit and 
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what can we do about it to prevent those falls in the future, improving the general 
health outcomes of our patients. For sure, this is big today-- reducing cost- to the 
organization.  You know, that is an important thing that we really deal with on a 
daily basis.  I mean, my recent work has been looking at the efforts of the team 
and how do we capitalize on that and how do we minimize hand-offs, make 
efficient use of all of our resources-- rooms, equipment, staff, docs, you name it. 
What’s the best way to make efficient use of the team and everything required?  
This response from Participant 8 described a myriad of practical applications of using 
managerial epidemiology to impact patient satisfaction, cost, and health outcomes which 
can be often daily priorities for ambulatory health services leaders. 
 Continuing on with health outcomes, Participants 12 and 5 provided insight on 
how managerial epidemiology supports improving patient care. Participants 12 discussed, 
Absolutely [agrees that without managerial epidemiology there would be 
implications to the triple aim].  I think – I mean we say that quality of care is top 
notch all the time.  And it really is, but the patient has a much better quality of 
care when they have the most appropriate treatment.  And that might not be the 
case if we couldn’t hone in on the patients who would benefit the most from these 
new therapies. 
From this response, it is evident that using managerial epidemiology for identifying 
proper treatment for patient populations can improve quality of care.  Additionally, 
Participant 5 shared,   
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I mean, the managerial epidemiology is compatible within the current role 
because we are using clinical data all the time to help to make comparisons to 
determine what the right course of action is for patients.  You know, do we have 
the right mix of staff, do we have the right mix of… are we doing things in the 
most optimal way.  So, yeah, I think we can use it regularly to help us to improve 
the care we are providing. 
Not only did this response from Participant 5 corroborate that managerial epidemiology 
can help leaders improve patient care, but it also assured me that managerial 
epidemiology is also compatible for leaders to do so. 
In conclusion, it is evident managerial epidemiology can improve organizational 
performance by impacting the triple aim.  Additionally, organizational performance 
metrics and leadership goals are tailored to the triple aim and could use managerial 
epidemiology for their development as well as for the operating plan.  In the previous 
theme, I discussed the use of managerial epidemiology for transforming healthcare 
towards a population health approach. As Participant 10 described, this population health 
approach is more of an “action plan” to create congruencies from organizational goals 
and leader goals down to the front line.   
Current Level of Adoption is Variable 
Despite the benefits of managerial epidemiology and the participants’ 
perspectives on impacting the triple aim and overall organizational performance, 
participants reported variable adoption levels of managerial epidemiology. While a 
68 
 
couple participants like Participant 1 and Participant 3 did not recognize the term, they 
did recognize the use of the practice.  Participant 1 stated,  
I would think it [managerial epidemiology] is very much integrated.  I don’t think 
we use that term today.  But I think that is -- We have formed complete separate 
divisions in the health system get good at that so we can make good decisions and 
we can be effective managers… I think—there might be still a percentage of folks 
who do not utilize it [managerial epidemiology] and go off of how we’ve always 
done it.  I think effective management teams out there utilize data in ways that 
work in the past and help educate those around them. 
Participant 1 noted that the term, managerial epidemiology is unfamiliar to some 
ambulatory healthcare leaders. They may be adopting the practice of managerial 
epidemiology through the support of a team but not calling it managerial epidemiology; 
additionally, some ambulatory healthcare leaders might not use it.  .  Similarly, 
Participant 3 mentioned,  
So, for managerial epidemiology. You know, I think a lot of people do this, but 
they just don’t call it that.  
In the same vein, Participant 10 noted, 
I might not be the right guy to ask, I live and breathe it [managerial 
epidemiology].  I mean, the organization might not be ready for it or the term. 
A different perspective was provided by Participant 9 who shared,  
I think it [the use of managerial epidemiology] has to happen.  I think it 
[managerial epidemiology] does happen.  I think sometimes it [managerial 
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epidemiology] happens more purposefully than others.  I think sometimes people 
are more aware of it [managerial epidemiology] than some.  Some by default, 
back into it [managerial epidemiology], but they get there. 
This interesting response from Participant 9 was interpreted that the variable adoption of 
managerial epidemiology is achieved often by happenstance rather than purposeful 
implementation. 
Participant 11 provided the perspective that there is a slow awareness and poor 
adoption level of managerial epidemiology,  
Like people are just knowing this [managerial epidemiology] is important.  
People, they notice, but they are just misinformed or are just too busy to do it.  
Where I am just with people who are at least attempting to think outside of the 
box, to think of different solutions to different problems. None. I mean, one 
conference touches a little bit of this.  The other conferences do not touch it at all. 
From this response, it is evident the awareness and importance of using managerial 
epidemiology is starting to emerge; however, managerial epidemiology not consistently 
adopted.    
In contrast, others such as Participant 4 reported that they did not see any 
adoption of managerial epidemiology.  While others such as Participant 5 seemed unclear 
of the specific terminology of managerial epidemiology but based on the definition did 
not believe that it is being adopted.  And lastly, Participant 12 expressed that some 
leaders use superficial data, but some do not use any data at all.  Participant 4 noted the 
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lack of adoption of managerial epidemiology, as well as lack of general awareness by 
senior leaders.  
Right now, our current practices don’t even focus on managerial epidemiology… 
It is currently not used here yet.  No, I don’t think half of them [senior leaders] 
know what it is. 
Similarly, Participant 5 highlighted the unfamiliarity with the term, managerial 
epidemiology and the lack of adoption , “Um, can you define a little bit better on the 
managerial epidemiology term. That’s not a term that I’ve used…Maybe we do use it 
more here or equivalently, but I don’t think so.”  Sharing a similar weak adoption of 
managerial epidemiology, Participant 12 shared that there was a weak level of adoption 
by colleagues. 
I definitely have colleagues who take more of a hands-off approach to the data—
they look at all of the top-line data and they look at the productivity for their 
physicians and throughput for their patients, but they don’t do a deep dive to 
discover… 
In summary, current adoption of managerial epidemiology is clearly not 
integrated across the United States healthcare system.  Participants reported variable 
adoption levels ranging from well-integrated within the healthcare organization, weak 
levels of integration, use of data but not managerial epidemiology, to no adoption. 
Consistently, participants expressed a lack of awareness with the term, managerial 
epidemiology.  The term was unfamiliar even to participants who reported a high level of 
integration of using managerial epidemiology.  Even at an organization characterized by 
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well-integration of managerial epidemiology, the use of managerial epidemiology by 
some leaders was still variable.  Additionally, current adoption of managerial 
epidemiology occurs spontaneously rather than concerted implementation which could be 
the culprit of variable adoption.  It is evident there is opportunity for hardwiring the 
adoption of managerial epidemiology and creating awareness on the term itself to 
capitalize on its benefits.  
 
Research Question 2 
The second research question explored was as follows: What are the perspectives 
and experiences of ambulatory healthcare leaders regarding communicating the use of 
managerial epidemiology through the healthcare system?  To answer this question, 
participants were asked about the difficulties for ambulatory leaders in using the practice 
of managerial epidemiology and ways for mitigating these difficulties.  Additionally, 
participants were asked about ways to easily test the practice of managerial 
epidemiology.  Two key themes were elicited from the interviews and open-coding 
analysis. The first theme I will discuss elaborates on the barriers of adoption of 
managerial epidemiology.  Lastly, I will close this section by sharing the last theme 
which includes recommendations for improved adoption. 
Leader Competency and Data Challenges are Barriers for Adoption 
More than half of the participants (58%) discussed leader competencies as a major 
barrier for adoption of managerial epidemiology.  The majority of these participants 
shared insights on the potential driver of competency challenges being skill-sets such as 
72 
 
analytical skills and strategic thinking.  Participant 10 exclaimed, “The #1 thing is you 
have to have a competency first.”  Similarly, Participant 1 shared, “It could be the 
analytical ability of some managers. They might be really good people, but they can’t—
they aren’t strong at finding the support through the data.  It is a skillset”.  It is evident 
the analytical skills may be a competency barrier for the adoption of managerial 
epidemiology.  Participant 8 elaborated on this competency challenge stating,  
Our clinic managers are people you know—many of them grew up through the 
ranks. So they started as a scheduler or a supervisor and kind of continuously 
added to their scope and become effective managers in terms of building a team 
and kind of understanding the operations and why—why we got to where we are 
today- they have that historical knowledge but they do not have these technical 
skills. And, we are in our department really deficient of people that have these 
skills.  It is a real impediment to us—always doing the right thing and using data 
to inform decisions… I think that you know, while we have a lot of people that 
don’t have a lot of skills.  Actually, in the department, there’s a real deficit of 
individuals with analytic skills. 
The competency barrier impeding the use of managerial epidemiology, technical skills, 
noted by Participant 8, are a detriment to departmental performance.  Participant 8 also 
noted that people may advance in the organization without gaining these skills, which 
impedes the use of managerial epidemiology. Participant 3 expressed similar concerns of 
leaders rising in organizations without the appropriate, needed competency for using or 
adopting managerial epidemiology. 
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Well, there’s a couple of factors. The first would be competency.  So, depending 
upon where you are in the country, some managers don’t have a lot of education.  
Maybe they legacy-ed their way to a leadership role.  Maybe they’ve worked 
there for 30 years and they believe they know everything, but they struggle with 
some of these fundamental things.  The other thing would be the understanding of 
quantitative methods.  You don’t have to be a statistician, but you do need to 
know the difference between mean, median, and mode which kind of laugh at in a 
haphazard kind of way because sometimes I ask managers these questions and 
they don’t know. And I have to just kind of not say anything condescending, but 
also—you should know the difference between mean, median, and mode that is 
the most basic statistical analysis. 
Participant 3 elaborated on the knowledge and skillset gap for even the basic principles 
needed for using managerial epidemiology.  Similar to Participant 8, Participant 3 
expressed this can be caused from rising internally through the organization with 
institutional knowledge and lack of other knowledge such as skillsets for using 
managerial epidemiology.  Participant 3 also asserted geography and education could 
play a role in competency barriers to using managerial epidemiology. 
Not having the analytical competency for utilizing managerial epidemiology 
could generate fear as described by Participant 7 and Participant 12.  Participant 7 stated,   
Some folks might not have the skillset to interpret what they see or have a fear of 
it because some folks have a fear of numbers or not being able to read it 
appropriately.  Just because they don’t use it all the time. 
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I interpreted this response as some ambulatory healthcare leaders could struggle reading 
reports or understanding numerical data because they do not engage in the task frequently 
which could cause fear of using managerial epidemiology.  Similarly, Participant 12 
shared,  
That sort of stuff [such as dashboards] at a high level makes it easier for them to 
understand that it is all coming from those gigantic spreadsheets that are scary to 
them, but it doesn’t have to be.  If you work with somebody who is experienced 
or seasoned enough to collate the data and collect it in a meaningful way, data 
analytics can be very useful. 
I interpreted the response from Participant 12 as  ambulatory healthcare leaders can be 
fearful of analytical data; however, this response reiterated the utility of the information 
provided from practicing managerial epidemiology and the availability of resources such 
as tools or experienced colleagues can help with adoption.  The remainder of participants 
answered these questions with recommendations for adoption rather than detailing 
difficulties such as a need for culture change or stakeholder engagement.  These will be 
discussed in the next theme section.   
Besides the key barrier of leader competency, another well-represented barrier in 
the data analysis was data availability and accuracy.  More than 80% of participants 
discussed the major difficulties with data for adoption of managerial epidemiology which 
included data integrity, accessibility, and reporting.  Responses described that data is 
sometimes not accurate or conflicting across sources.  A main source of data collection 
described by participants was via an electronic health record (EHR).  Participant 1 
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discussed the challenges specific to EHR integration and interoperability by stating, “you 
can’t do population health without interoperability between systems.” Participant 2 
mentioned EHR data for managerial epidemiology is “only as good as what you put in.”  
In addition, data is stored and extracted from multiple sources which creates 
inefficiencies and confusion as described by Participant 12, Participant 2, and Participant 
3.  Participant 12 noted,  
One thing that we definitely have an overload on is information.  16 different 
scorecards to look at to discover a whole host of information about patients and 
practices across the institution.  And while it’s great to have all of that 
information at my fingertips, it can also lead into information overload. So, it can 
sometimes slow down the process as well because while this dashboard says one 
thing and another pulling from a different system says another thing.  Which one 
do we go off of?  And how do we reconcile the two? 
Participant 2 provided more detail about data types and delay in receiving data by 
sharing,  
And certainly, some of that is due to our inability to access timely data.  Often 
times, many people are working off of claims data for a given population that is 
not super timely because you’re looking at EHR data that may not be the full 
picture- or trying to combine the two.  Um, which can be really challenging 
depending on which payers you’re working with… I think we want everyone to 
be speaking the same language and accessing the same data. 
Giving additional perspective on data sources and data integrity, Participant 3 elaborated,  
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But they [data elements] live in several different databases… It is just a matter of 
patience and time.  So, I could say give me the same analysis to an administrator 
who doesn’t have those resources. They would be able to pull it together in what I 
would say is a reasonable timeframe, if they know what they are doing, if they 
have an analyst that can think critically. But if you don’t have that, then you 
spend a lot more of your cognitive time on building and essentially coming up 
with the template. And it tends to be very manual. So, you’ll have an abstraction 
period, you’ll have a quality assurance period. It only takes one person keying a 
number in wrong and it throws everything off. So, again it’s not insurmountable. 
It can be managed, and it could be managed well if your scale is smaller… If you 
work for a really small group, that didn’t invest in the IT infrastructure, you’re 
never really going to have real time data. You’re always dependent upon a 
monthly report that may or may not be accurate.  Your data integrity struggles.  
That’s another piece of it as well- understanding data integrity.  Those are a few 
key factors. 
Even with multiple data sources, access to data is limited and restricted to 
ineffective distributions of dashboards.  Further, to request access to data or for a specific 
report, a lengthy requesting process is required.  Moreover, interviewees described 
reports as being inflexible, overloaded with information, or hard to read for some leaders.  
Participant 7 detailed the struggle of having too much data or too little data and 
complications with finding the balance by discussing,  
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Access to it [data].  So, a lot of folks don’t have the skillset.  You need to have the 
right folks to analyze the data and you need to have the data available.  You 
know- where I am at, we have the [software name] system which is huge.  It is 
really great at looking at the population and understanding what their needs are. 
Not everyone has that.  So, just being access it and utilize it in a way that works 
for you could be a barrier… We are so data driven.  Everything we do, we rely on 
data for.  We probably do more than we should.  In certain settings, because we 
rely on the data so much that there’s analysis paralysis, you know what I mean.  
So, decisions are made based on data/ variables… Maybe you use the data and 
exclude a certain population of patients or withholding what might be helpful for 
them so you know- if you are only looking at what’s available, you might not be 
providing something that’s actually needed… 
Participants 8 and 12 elaborated on the laborious, lengthy process for submitting a data 
request, the inflexibility of report structure, and the delay in receiving the reports.  
Participant 12 noted that requesting data or report changes as a “herculean effort.” 
Participant 1 described the strain on the health system caused by the siloed data housing 
and numerous reporting and measurement requirements by the various government 
programs and payer relationships.  Participant 1 provided an example of the same 
healthcare service such as mammography having various screening metrics depending on 
the payer.  Participant 1 explained, 
It used to be that people would track things [data] in different silos.  And you 
might ask a question and the answer would depend on who you were asking in the 
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hospital…You know, there’s obviously claims data, government big data, 
hospital, ambulatory separated into silos.  So, I think the more that we can 
normalize data across different players—it would be helpful.  For example, 
different payer relationships that we have with the hospital, they might try to 
incentivize us to have a high mammogram percentage rate for their population.  
They’re on the hook for these folks.  They pay hospitals to help keep them 
healthy—great.  They all—United and Humana might have two different ways of 
calculating what a successful mammogram rate might be—they might have 
different denominators, different Ns, everything. They might have different 
thresholds.  Different annual, 5-year requirements vs. 4-year requirement.  It’s a 
lot of straining on the healthcare system to be able to do the work because there’s 
so many different rules. So, I think normalizing the data, normalizing best 
practices for each issue would help a lot.   
Participants 5 and 6 described data integrity challenges as well.  Participant 5 stated,  
Sometimes you get too much data, you know—we drown in information and we 
don’t do anything about it… I feel like we could use more data.  But it’s hard to 
get. It’s hard to get out of our systems right now.  To make it…make sure: 
Number 1- Validation is important.  Being able to actually locate it too is a 
challenge. The data is not always readily available, and the data is not always 
correct.  One of the biggest things: we do find holes in the data.  And we try to—
or we think that there are holes in the data, and we try to get them fixed. And in 
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my current role, I can’t always get people to pay attention to fix that stuff.  So, we 
just choose to ignore it [chuckle]. 
Participant 6 continued on this topic, 
We’ve had issues on not sure we are always getting the right data—like we are 
capturing the right information sometimes things seem more skewed than we 
thought… From a leadership standpoint, I think the overarching theme is really 
just data support. 
In summary, this theme shared barriers for adoption of managerial epidemiology 
which included competency and data challenges.  For leader competency, participants 
described the major barrier of analytical skills needed for managerial epidemiology. For 
data challenges, there were a combination of prominent issues including access to data, 
data integrity, and reporting.  The leaders’ fear for using managerial epidemiology might 
be amplified from not having the competencies needed to use managerial epidemiology 
not having confidence in the data.  In the next section, I will share the last theme which 
provides recommendations improving adoption of managerial epidemiology which may 
alleviate leaders’ fear.  
Recommendations for Adoption: People and Process 
All participants readily provided recommendations for improved adoption of 
managerial epidemiology.  I have grouped the recommendations provided by the 
participants into two categories: people and process as depicted in Figure 1. 
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Figure 1. Overview of recommendations for managerial epidemiology adoption. 
 
For people recommendations, 75% of participants described the need for human 
resources to mitigate the data barriers, close the gap for the competency challenge, and 
overall, support the use and adoption of managerial epidemiology.  Participant 5 
discussed the need for additional resources to improve the data integrity or “fix the 
holes.”  Participant 1 described the current use of a data analytical team by stating,  
We have formed complete separate divisions in the health system to get good at 
that [managerial epidemiology] so we can make good decisions and we can be 
effective managers.  
The majority of the participants discussed the need for a similar approach such as hiring a 
data analyst or scientist to provide actionable data.  For example, Participant 7 shared the 
need to hire a team member for support leaders lacking the analytical competency by 
discussing, 
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So, a lot of folks don’t have the skillset.  You need to have the right folks to 
analyze the data and you need to have the data available…So, it’s nice to have 
folks who actually have data available, who can run data and act on what data the 
managers need.  Those who can actually look at the data and be a part of the 
decision-making process and at the table. 
Participant 11 elaborated on the relationship between the leader and analytical team 
member by describing, 
So, I’d imagine- someone who has a lot of data points their trying to follow—
that’s where delegation is important.  Someone else who is following it more 
intimately and they you’re getting a high level every 3 months, 6 months, every 
year. And then, anything that comes up that needs to be addressed that comes up 
to you… Give them your top 3 priorities and have them work on that. 
Similarly, Participant 8 shared a real-time example of this recommendation by noting, 
Well, I actually think we need—I am actually advocating for this today—we need 
a clinical analytics person that is part of the department leadership team.  
Somebody that is-- can develop some reports that get send out on a very routine 
basis or just made available at all times, but then also someone that can be part of 
project teams.  That can be called upon to get data and to take a look at a couple 
of things and make some high level recommendations as to what’s the data is 
telling us and how can we design things so that it plays out the way it would be 
you know optimal. 
Participant 3 described their experience in hiring these team members by sharing,  
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I’ve been able to hire an analyst for the reactive side and a scientist for the 
proactive side. And my data scientist, I used to the full extent of their capability to 
really go into the population health data point to discover trends and very broad 
data needs that an analyst can only accumulate but cannot build the IT 
infrastructure that I’d need. 
 In addition to the personnel to support data analytics of managerial epidemiology 
for healthcare leaders, the people portion of recommendations focused on the current 
leaders and stakeholders.  Multiple participants such as Participant 4, 11, and 12 shared 
the need for multi-level awareness and engagement including C-suite leaders, ambulatory 
leaders, and providers.  For example, Participant 4 exclaimed, “The best way is going to 
be that everyone at senior level has to have buy-in.”  With a somber tone and a few 
pauses, Participant 11 shared the need for engagement by stating, 
And I’ve given up—not given up… I haven’t been putting the pressure on like I 
have been for a little bit because again, it is like herding cats. It can be a lot of 
work.  I think- you know it goes down to involving people in the process. For me, 
I just think that’s the way to do it the easiest without having to pull so many 
teeth—having people involved in the process whatever it is. 
I interpreted this response, the low tone of voice with pauses, and self-correction of “I’ve 
given up” that the participant seemed weary of their pursuit in engaging in using 
managerial epidemiology. 
Elaborating on engagement, Participant 12 stated,  
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So, you really need buy-in and support from all sides in order to really move the 
needle in any of those measures…  But really, we need buy-in from every part of 
leadership.  So, we have a triad model in most areas.  We have a scientific or 
physician leader, a nursing leader, and an administrative leader. 
Participant 10 stressed the need for C-suite buy-in and clout for the adoption of 
managerial epidemiology by sharing, 
The way to mitigate it is to have buy in from the C-suite.  Particularly, the CEO.  
Typically, they nod their heads and say this is the latest of the brand-new thing 
and we all know how that ends.  The important thing is there needs to be 
congruency up and down the organization and the sense of urgency, too… If you 
get dropped into a place where they’ve never heard of it or don’t think it is 
important. Then, it’ll be a long slog. I think most everybody is going to be in this 
organizational space.  But I think organizational readiness is going to be key. 
Participant 10 also suggested creating leadership position for using managerial 
epidemiology  practice which would indicate its importance to the organization.  
Engagement from leaders should also include communication and spreading 
awareness as commonly seen through the data.  Participant 9 shared the need to 
communicate the vision and role for all stakeholders in using the practice of managerial 
epidemiology and consistently use and communicate the practice in meetings to create a 
unified effort. Participant 9 explained,  
I think it is consistency, painting the picture, I think it is being very concise to 
what it means to each of the individuals particularly in management roles and 
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what the expectations are as well as what it looks like…I think just helping 
particularly the leaders gain an understanding not only in what it is, but how you 
apply it.  Then, I think living it in all your meetings. 
Additionally, participant responses detailed the need for culture change as described by 
Participant 4 who discussed, 
Well, like anything else that’s new, there’s going to be culture change. It will be 
changing the culture to this.  So that’s the biggest challenge especially the culture 
here.  It is very unique.  To implement something like that, it would be major 
strategic planning with a focus on a cultural paradigm shift…The best way is 
going to be that everyone at senior level has to have buy-in. We’d have to build a 
strategic plan to ensure the right resources and tools in place to integrate this into 
the culture. 
Participant 3 elaborated on the critical nature of culture for hardwiring adoption of 
managerial epidemiology by sharing, 
If I train you in it, you’ll say that’s nice and good to know, but if I don’t hold you 
accountable for using that then it is all for nothing.  So, what you fundamentally 
have to do is change the culture and say, “This is the way we are going to manage 
our business”. So, the way to make is successful is to make is system-dependent 
which again comes from a cultural standard. And then, allows every decision you 
make has to filter through all the same things that everyone should be looking at. 
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In addition to engagement efforts and culture change, Participant 9 discussed the 
need for education.  Participant 9 exclaimed with a chuckle, “I am a big believer in 
education.”  Participant 4 discussed this idea further by sharing,  
I think what we would have to do is we would have to first go back to the 
grassroots and ensure we train everyone to be sure they understand what this 
model is.  And reframe orientation, processes, and governance structure around 
this model. 
To support education and training, Participant 3 suggested visual boards to hardwire the 
learned skills and process.  Participant 1 elaborated on leveraging training with effective 
managers already using managerial epidemiology.  Participant 1 noted, 
I think effective management teams out there utilize data in ways that work in the 
past and help educate those around them. There are ways—right and wrong in 
some regards that you can prove through data.  Just wide-spread adoption. 
 In addition to focusing on the people aspect of recommendation for adoption, 
participants shared recommendations for an adoption process.  Participant 7 mentioned 
the need for a process and commitment to include the analytical personnel in decision-
making in order to be a source of recommendations to leaders. Participant 7 described, 
“Those who can actually look at the data and be a part of the decision-making process 
and at the table.” This inclusive approach of integrating the data analytic team member in 
decision-making could better support the use of managerial epidemiology.  
In addition to creating a process and environment for analytical personnel to be a 
part of the decision-making, the participants also shared insights on improvements to 
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characteristics of reports that will support testing the use of managerial epidemiology.  
Participants 3, 7 and 11 suggested the deliverables should be easy to access, timely, easy 
to interpret, and actionable.  Participant 3 simply stated, “I think managerial 
epidemiology hinges largely on ease of use and accessibility.” Participant 7 shared the 
same viewpoint, “I think making it easy for folks to access or easy to read and interpret.”  
Participant 11 elaborated, 
I think it is extremely helpful, but it needs to be done in a way that is useful and 
that is practical… So, the data is 100% important, but it has to be presented in a 
way where people aren’t labored by it.  I think right now there are a lot of data 
being presented that more laborious, helpful at the same time.  But it needs to be-- 
the scale needs to be completely disparate and it needs to be much more helpful 
than it is laborious… And getting the data that you’re actually going to act on. 
For adoption of managerial epidemiology, multiple participants such as 
Participants 1 and 2 recommended the use of a tool to guide leaders such as a checklist, 
standards, framework or process.  Participant 1 explained, 
Maybe have a process in place where you need to justify a position of yours. 
Maybe a requirement is some kind of measure of some kind.  Make it a process-
driven decision. 
Participant 2 elaborated on the need for a process and tool to be adaptable for multiple 
settings by stating, 
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So, I think creating standards that can apply across many different diverse 
specialties, primary care, inpatient, outpatient settings. I could see that being 
challenging if we did not have an agile way. 
Participant 3 shared this belief as well as urged for managerial epidemiology tools or 
processes to be  leader-independent for sustained adoption.  Participant 3 noted,  
I mean, with anything- if you have some very tangible, tactical tools like a one-
page checklist or excel doc or something that can do some of the passive analysis, 
then there is a great adherence no matter what you’re talking about… A lot of 
people take new positions in leadership and they don’t know what they’re doing.  
They may have just been promoted and they may have a lot of strong qualities, 
but they’re just trying to figure it out.  So, if you can give them some tool/ process 
that is not dependent upon one leader who might have left or a data dump 
everything on you—you’re probably for the better. 
The majority of the participants suggested an easy way to test managerial 
epidemiology is to “just start doing it” as Participant 11 shared.  Participants 2, 4, 7, and 
8 recommended using a pilot or a small intervention to get ambulatory leaders using this 
practice of managerial epidemiology. Participant 2 described a pilot with clinic leaders 
first before broad adoption of managerial epidemiology by sharing, 
I think that you could start to pilot it—umm, my two cents would be to pilot it 
with those close to the front line so practice managers and administrators who are 
making decisions that are informing clinic populations.  Then, understanding 
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either how it’s helpful, not helpful, what could be tweaked to inform a broader 
push. 
Participant 8 shared an engaging approach early in pilot development by discussing, 
They would have to see some sort of data that is compelling and help them wrap 
their head around what the data is suggesting. And then, you know--agree on a 
pilot or some sort of a plan for you know, re-designing the workflow or whatever 
it is we are working on. 
Participant 7 explained, 
Exactly that.  So, you could look at small subsets and make small decisions and 
put things into place to see what happens for a short period of time. There’s not a 
huge investment there financially or manpower or capital expenditure.  So, that 
you could do to test it out. 
The value of this pilot approach was discussed by Participant 4 when stating, 
I could probably build a program where we can test this model to see how it 
works and be able to measure pitfalls as well successes around it.  And, build 
strategies and opportunities for the area of weakness. 
In contrast, Participant 9 shared a similar action-oriented perspective as Participant 11, 
“Honestly, I get a little antsy with pilot testing because I like to charge forward.”   
In summary, the participants provided recommendations to solve the competency 
and data challenges as well as improve the overall adoption of managerial epidemiology. 
An overview of recommendation for adoption of managerial epidemiology was shared in 
Figure 1.  It is evident from the data analysis that data analytical team members should be 
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hired to support ambulatory healthcare leaders in decision-making.  In addition, 
engagement from all levels of the organization, especially senior leaders, is required for 
adoption of managerial epidemiology.  Supported by senior leaders, culture change is 
recommended for this new practice which can include use of strategic planning efforts.  
Moreover, training should be provided to ambulatory healthcare leaders and hardwire the 
learnings of using managerial epidemiology with agile tools that are both leader and 
setting independent.  Lastly, pilots are recommended to begin use of managerial 
epidemiology before broader expansion. 
Evidence of Trustworthiness 
Credibility 
For credibility of my study, I employed strategic sequencing of methods, dialogic 
engagement, participant validation, and structured reflexivity practice, as outlined in 
Chapter 3.  Strategic sequencing of methods was significant for this study.  I thoughtfully 
grouped the interview questions to flow easily and resemble more of a conversation with 
the participants to enhance comfort.  The interview questions started with a section to 
build rapport with the participants by asking questions to get to know them as an 
individual and a leader.  After, the questions were purposefully outlined in conjunction 
with the DoI theory.  Dialogic engagement was achieved through sharing my methods 
and interview guide with my dissertation committee who provided feedback before the 
start of the study.  Importantly, participant validation was used by providing the verbatim 
transcripts to all participants in the follow-up thank you email.  This was sent prior to 
coding of the data.  Participants were encouraged to provide feedback as they saw fit to 
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ensure I captured their responses accurately.  They were also able to provide any 
additional information.  None of the participants responded with any changes or additions 
to the transcripts.  Lastly, structured reflexivity was used by visually mapping codes, 
categories, and themes to channel bias and challenge interpretations. 
Transferability 
Transferability was assured by providing a detailed description of the problem 
statement and background during the recruitment process and within the consent form.  
Additionally, definitions of key terms were provided.  Managerial epidemiology was 
defined multiple times at the beginning of the interviews and throughout the interviews as 
requested by the interviewee.  Participants were encouraged to stop me at any time during 
the interview to provide any definitions or clarification.  Additionally, the relevance for 
this study and the study findings are applicable to ambulatory healthcare leaders as 
reflected in participant responses that managerial epidemiology is critical for the 
functions of ambulatory healthcare leaders. 
Dependability 
For dependability, I aligned the research methods and framework to ensure data 
stability.  The traditional qualitative method using semistructured interview technique 
provided robust, meaningful data.  It is suspected that using any other method would not 
have produced enough data for saturation and thematic analysis.  Moreover, the use of 
DoI as framework to align the interview questions ensured the data gathered would 
answer my research questions more completely. 
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Confirmability 
The sole strategy used for confirmability of my study was structured reflexivity.  
Visual mapping was crucial in outlining codes, categories, and themes to generate 
interpretations.  This strategy channeled my biases and challenged my interpretations.  
Visually mapping the coding process helped focus my attention on the codes that were 
present in the interviews rather than external factors. Verbatim transcription of the 
interviews also supported confirmability as well as using preset codes.  Throughout the 
study, my dissertation committee was encouraged and expected to provide feedback and 
challenge my research process.  This primarily occurred before starting my pilot study, 
during my pilot study, and before starting the formal study.  My dissertation chair 
reviewed the de-identified verbatim transcripts from my pilot study to ensure the data 
was meaningful, deep enough, and answered my research questions before moving 
forward.  We also met to review if any adjustments were needed before interviewing 
additional participants for my formal study.  We did not find any adjustments needed.  
The final oral defense will be another mechanism for challenging my process and 
thinking in this study. 
Summary 
The purpose of my study was to understand the perspectives of ambulatory 
healthcare leaders on the use of managerial epidemiology.  Using the DoI theory as a 
framework, the interview questions enabled an understanding of the diffusion of 
managerial epidemiology as well as recommendations for adoption.  In Chapter 4, I 
shared the recruitment process following a purposeful sampling method as well as the 
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consenting process and pilot study.  For each of the two research questions, I organized 
my findings by theme.  Despite variable adoption levels, the use of managerial 
epidemiology was discovered to be critical and without disadvantages.  It was also 
discussed as beneficial to population health and contributing to the triple aim and thereby, 
overall healthcare system performance.  Importantly, the barriers for adoption were 
explored and found to be ambulatory health services leader competency and data 
challenges.  My findings were concluded with an in-depth discussion of 
recommendations for adopting managerial epidemiology which included both a people 
aspect as well as process needs.  Lastly, I shared the process for upholding 
trustworthiness of my study including the credibility, dependability, transferability, and 
confirmability of the study.  
In Chapter 5, I will discuss my interpretations of the findings as well as any 
limitations of the study.  In addition, I will share overall recommendations from the study 
and implications of positive social change.  Finally, I will close Chapter 5 with a 
description of my experience as the researcher. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
This study was aimed at understanding the perspectives of ambulatory healthcare 
leaders on the use of managerial epidemiology, a practice shown by previous literature to 
have the potential impact on the triple aim but has not been widely adopted.  This is the 
first study to explore ambulatory healthcare leader perspectives on managerial 
epidemiology, and thus expands the knowledge in the discipline.  The study was 
conducted in a traditional qualitative research design by interviewing 12 participants 
recruited through purposeful sampling method.  The two main research questions and 
subquestions were as follows: 
Research Question 1: What are the perspectives and experiences of ambulatory 
healthcare leaders on the use of managerial epidemiology for decision-making? 
Research Question 2: What are the perspectives and experiences of ambulatory 
healthcare leaders regarding communicating the use of managerial epidemiology through 
the healthcare system? 
Subquestion 1: What are the perspectives and experiences of healthcare leaders in 
ambulatory healthcare settings on the relative advantage of the use of managerial 
epidemiology? 
Subquestion 2: What are the perspectives and experiences of healthcare leaders in 
ambulatory healthcare settings on the compatibility of the use of managerial 
epidemiology? 
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Subquestion 3: What are the leaders’ perspectives and experiences of healthcare 
leaders in ambulatory healthcare settings on the complexity of the use of managerial 
epidemiology? 
Subquestion 4: What are the perspectives and experiences of healthcare leaders in 
ambulatory healthcare settings on the trialability of the use of managerial epidemiology? 
 There were multiple key themes from this study.  The first theme derived from the 
data analysis was that managerial epidemiology is critical and presents no disadvantages.  
The next themes were that the practice of managerial epidemiology brings objectivity to 
decision-making and supports healthcare transformation, including impact on the triple 
aim and overall system performance.  Another theme was that the current adoption of 
managerial epidemiology is variable.  The fifth theme was there are challenges of 
leadership competency and data issues.  The final theme included recommendations for 
adoption encompassing people and process change management.  
In Chapter 5, I provide a discussion of my interpretation of these findings 
compared to the literature as well as limitations of the study.  Additionally, I provide 
recommendations for further research in the discipline of managerial epidemiology.  To 
close this chapter, I discuss the implications including the impact on social change. 
Interpretation of Findings 
In this section, I share the interpretation of my findings from the study in 
comparison with the literature.  Although many of the study findings validate existing 
literature on managerial epidemiology, there are significant findings that further elaborate 
on the discipline of healthcare administration by lending new insights on managerial 
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epidemiology.  I will compare and describe the relationship of the study themes with 
literature on education of managerial epidemiology, unconscious bias, evidence-based 
management using managerial epidemiology, and current workforce adoption of 
managerial epidemiology.  Lastly, I will discuss how this study supports or rejects the 
theoretical framework before transitioning to study limitations. 
Managerial Epidemiology 
Education 
Based on the literature, there is inconsistency in a managerial epidemiology 
curriculum being provided in healthcare administration programs despite the benefits of 
the practice, the need for this application in the healthcare system, and healthcare leaders 
shifting to a population-based approach (Caron & Hooker, 2011).  Consistent with the 
literature, most of the participants in this study were not aware of the term managerial 
epidemiology.  The inconsistency of adoption of managerial epidemiology and gap in 
leader competencies also confirm findings in the existing literature that most leaders with 
healthcare administration degrees did not receive the education necessary to apply the 
practices for a population-based approach such as managerial epidemiology. The findings 
of this study, that leadership competency is a key challenge to adoption of managerial 
epidemiology, validate the literature indicating that healthcare leaders lack and need the 
competency in population-health approaches such as managerial epidemiology (Caron & 
Hooker, 2011).  Although researchers have discussed the need for academia to include 
curriculum on managerial epidemiology, the findings from this study elaborate on the 
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discipline by offering insights on adoption for leaders already in the workforce, starting 
with ambulatory healthcare leaders (Caron & Hooker, 2011).   
More than 70% of participants had completed a healthcare administration-related 
degree and participants’ years of ambulatory leadership experience ranged from 2 to 45 
years.  These findings validate that there continues to be a gap in managerial 
epidemiology courses offered in academic settings and curriculum (Caron & Hooker, 
2011).  This is contrary to a recent textbook that noted many academic programs include 
a managerial epidemiology course (Khaliq, 2018). For the first time, this study extends 
the knowledge of healthcare administration by offering challenges and recommendations 
for the use of managerial epidemiology for current ambulatory healthcare leaders.  These 
challenges and recommendations should also be considered for inclusion in academia for 
emerging healthcare leaders.  This will be discussed later in the recommendations 
section. 
Unconscious Bias 
The study also elaborated on the discipline by exploring the advantages and 
disadvantages of managerial epidemiology.  There were no disadvantages for using 
managerial epidemiology based on the data analysis.  However, an important response 
from a participant did highlight a challenge that needs to be considered.  Specifically, 
Participant 7 discussed unconscious bias of the leader or analyst, which could cause them 
to inadvertently miss populations or characteristics of populations.   
Bias in managerial epidemiology has been discussed as it relates to specific 
epidemiology practices such as length bias and lead-time bias in screening programs 
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(Fleming, 2015).  Unconscious bias is only referenced briefly related to epidemiological 
bias, but unconscious bias of the leader using the output from applying managerial 
epidemiology was not explored in the leader’s decision-making, or how it can be carried 
throughout their managerial functions (Fleming, 2015; Fos et al., 2018; Khaliq, 2018).  
Unconscious bias exists in everyone in any role, but unconscious bias in healthcare 
professions is shown to correlate with lower quality of care (FitzGerald & Hurst, 2017). 
Although neither the literature nor this study explored the unconscious bias of the leader 
when directing the analytical personnel conducting managerial epidemiology, this study 
has uncovered another gap in the discipline: the understanding and effects of unconscious 
bias by health services leaders in using managerial epidemiology.  It is important to better 
navigate unconscious bias particularly with managerial epidemiology as it focuses on 
health services delivery for patient populations.  Unconscious bias related to managerial 
epidemiology could cause inadvertent negative impacts of health services provided for 
populations which raises ethical concerns.  
Evidence-Based Management 
Existing literature addressed epidemiology as being critical for healthcare 
managers and their functions such as planning and directing (Fleming, 2015; Khaliq, 
2018).  The findings of this study, the first to explore the perspectives of ambulatory 
health services leaders on using managerial epidemiology, provide confirmation on the 
critical nature of applying managerial epidemiology and need for evidence-based 
management. Regardless of the variability in the participants’ adoption or awareness of 
managerial epidemiology, the essential nature of utilizing managerial epidemiology was 
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recognized by all participants.  Additionally, this study validated that use of managerial 
epidemiology can impact the triple aim of improved access, reduced costs, and enhanced 
quality, as well as overall healthcare system performance.  
The literature indicated that planning follows a historical pattern and is often 
based on employees’ experiences (Fleming, 2018).  This study confirmed and expanded 
on existing literature that managerial epidemiology should be included in managers’ 
planning function, especially strategic planning and operational planning of a healthcare 
organization (Fleming, 2015; Khaliq, 2018).  The findings of this study reinforce that 
managerial decisions should use evidence and elaborate on how the practice of 
managerial epidemiology can be supportive by finding that current healthcare leadership 
decisions are often subjectively based on individual experiences and using managerial 
epidemiology can provide objectivity to the decision-making process.  Specifically, the  
objectivity is gained through the use of managerial epidemiology providing a better 
understanding of the population that the healthcare organization or leader serves.  
Further, study findings expanded on the literature to suggest the use of managerial 
epidemiology in goal setting processes and goal congruency from senior healthcare 
leaders such as the chief executive officer to the front-line leaders of ambulatory 
healthcare clinics.  Moreover, this study examined the use of managerial epidemiology 
for population health strategies to impact the triple aim for the population.  This study 
discovered and strengthened the use of managerial epidemiology as a tool for healthcare 
transformation namely population health including the value-based care healthcare model 
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as well as supporting leaders in the shift of patient volume from hospital settings to the 
ambulatory settings (Fos et al., 2018).  
To illustrate the potential use of managerial epidemiology throughout a healthcare 
organization, Figure 2 was created to incorporate the current literature with the findings 
of this study.  The interpretation of the data analysis led to the understanding that the 
population being served is at the center of the healthcare organization and managerial 
epidemiology can be used throughout the organization’s strategic plan, operating plan, 
leader goals, and population health strategy.  By using managerial epidemiology, 
healthcare leaders can create multilevel congruency towards the triple aim and support 
overall organizational performance.  As portrayed in Figure 2, the population and the 
population’s needs are central to the functioning and performance of the healthcare 
organization.  In this figure, population health strategy refers to both the organization’s 
population health strategy broadly, as well as the strategy for the populations that the 
leaders and their departments or clinics serve.   
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Figure 2. Managerial epidemiology used for alignment of strategic planning. 
This study validated the use of managerial epidemiology in planning and 
expanded upon the concept that using managerial epidemiology throughout the healthcare 
leaders’ planning and goal setting process ensures objectivity and impact on the triple 
aim of access, quality, and cost.  Managerial epidemiology can align throughout an 
organization and support transforming healthcare leaders from being focused on 
managing sick individuals to managing based on the population (Fos et al., 2018; Khaliq, 
2018).  In addition to planning and transforming, this study also validated and elaborated 
on the application of managerial epidemiology for assessing the effectiveness of a 
healthcare system (Caron & Hooker, 2011).  Managerial epidemiology could evaluate the 
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effectiveness of each element in Figure 2: strategic plan, operating plan, leadership goals, 
and population health strategy as well as the actual impact on the triple aim.  I will come 
back to this topic in later sections for recommendations and implications. 
Current Workforce Adoption 
Importantly, this study confirmed and elaborated on the existing literature that 
demonstrated the need to shift from traditional management towards a population-based 
model (Fos et al., 2018).  This study further reinforced the need for new competencies in 
population-approaches and skillsets for leaders such as managerial epidemiology (Love 
& Ayagi, 2015).  While there is some uptake of managerial epidemiology curriculum in 
healthcare administration-related academic programs, this is the first study to explore 
adoption of the practice by the current workforce of ambulatory healthcare leaders.  The 
findings highlighted that managerial epidemiology adoption is not hardwired and is 
highly variable, requiring efforts to increase the adoption for current ambulatory health 
services leaders in addition to new graduates. 
Although this study confirmed the need for ambulatory health services leaders to 
use a population-based approach, and the current lack of leadership competency in using 
managerial epidemiology, this study expanded on the literature finding that ambulatory 
healthcare leaders need not be the experts in managerial epidemiology themselves (Caron 
& Hooker, 2011; Fos et al., 2018).  Specifically, findings of this study included that 
ambulatory healthcare leaders need data analysts or scientists who utilize managerial 
epidemiology to assist them with the tools needed for their decision-making.  Thus, 
ambulatory health services leaders do not need the expertise to perform managerial 
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epidemiology themselves, but they do need to have the knowledge of the practice of 
managerial epidemiology and understand the concepts as it relates to healthcare 
administration in order to inquire, direct, and collaborate with their data personnel for 
enhanced decision-making and improved organizational performance.  This approach 
would also consider not burdening ambulatory healthcare leaders with additional work 
that might be required to overcome fear, to learn the practice of managerial 
epidemiology, and to incorporate the concepts into their individual leadership approach.   
Current literature and this study provided examples for how managerial 
epidemiology can be applied and explains the importance of ambulatory health services 
leaders using the practice; however, current literature does not discuss the adoption of 
managerial epidemiology nor the steps required for adoption.  The findings of this study 
can be used to address this gap in knowledge. Recommendations for adoption of 
managerial epidemiology provided by participants in the fourth theme (see Figure 1) 
were used to outline a two-phased framework of steps for current ambulatory healthcare 
leaders to use for adoption of managerial epidemiology (see Figure 3).   
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Figure 3. Steps for adopting managerial epidemiology in healthcare organizations  
Based on the study findings, Figure 3 outlines two phases for adopting managerial 
epidemiology in ambulatory healthcare organizations including people and processes.  
Starting with Phase 1, there should be a concerted effort on building engagement, 
aligning the organization’s culture with the use of managerial epidemiology, hiring a data 
teammate, and beginning training of the leaders and data team.  Phase 2 is focused on the 
processes required for adoption of managerial epidemiology.  This includes 
implementing a tool for leaders, revising the decision-making process, piloting the use of 
managerial epidemiology, and expanding the use of the managerial epidemiology beyond 
the pilot. 
For Phase 1, participants said that building engagement and creating buy-in can 
result from leaders communicating the vision for using managerial epidemiology.  Based 
on the research, healthcare organizations can establish a goal for ambulatory healthcare 
leaders to use managerial epidemiology which can support buy-in.  Likewise, using 
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managerial epidemiology at the most senior level for strategic planning can create 
broader engagement as well as culture alignment.  In addition to a new team member, 
engagement, and culture change, participants discussed that training was found to be 
important for ambulatory healthcare leaders in order to understand the model.  
For Phase 2, participants suggested a tool to help support ambulatory healthcare 
leaders in the adoption of managerial epidemiology that is actionable yet nimble to be 
applicable across many ambulatory healthcare settings. Participants also indicated that 
the tool must be adaptable for diverse settings as well as tactical to hardwire the adoption 
and not be dependent on the individual leader. To date, the need for a standard tool or the 
proposal of such tool for ambulatory healthcare leaders have not been discussed in the 
literature.  In addition to the tool, a revised decision-making process should be 
implemented to require the use of managerial epidemiology to justify the ambulatory 
healthcare leader’s position or decision.   
In addition to building managerial epidemiology into a decision-making process, 
inclusion of the data teammate at the table for decision making was suggested. The data 
scientist or analyst should be considered a key partner to the leader in decision-making 
rather than only a producer of reports.  Participants described the analytical partner as a 
collaborator in understanding the ambulatory healthcare leaders’ needs for data as well as 
offering analysis suggestions.  Further, participants suggested the new team member 
should provide recommendations to the ambulatory healthcare leader to support decision-
making. 
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Piloting the use of managerial epidemiology will create visibility to the practice.  
A pilot that is small and easy to trial should be used to not delay wider adoption.  This 
pilot could be a quality or process improvement effort, for example. Participants 
discussed piloting the practice of managerial epidemiology at the clinic level to inform 
refinements of using managerial epidemiology before expanding to healthcare leaders 
with greater patient population purview.  Once wins are seen from the small pilots, the 
awareness will help with enhanced engagement and the practice of managerial 
epidemiology should be expanded thereafter.  The steps for adoption (see Figure 3) 
including the leader tool will be discussed again in the recommendations section. 
Diffusion of Innovation 
In Chapter 2, I outlined existing literature on the underpinning theoretical 
framework for this study, DoI theory.  This is the first study on the discipline of 
managerial epidemiology to use DoI theory to research leadership perspectives on its 
adoption.  Of the five DoI theory attributes, four were explored in this study: relative 
advantage, compatibility, complexity, and trialability.  Observability was not included in 
this study due to poor adoption, which will be discussed later in the section on limitations 
of the study. The attributes of DoI were demonstrated to increase the rate of adoption 
(Rogers, 2003).  Therefore, the interview questions were aligned to understand each of 
these DoI components as it relates to the adoption of managerial epidemiology.  As a 
result, the themes that emerged from the data analysis aligned to the specific DoI 
attributes of relative advantage, compatibility, complexity, and trialability. 
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Relative advantage describes how the innovation is perceived as being better than 
what is existing (Rogers, 2003).  The relative advantage of an innovation is correlated to 
the rate of adoption (Rogers, 2003).  Meaning, if individuals viewed the innovation as 
being better than the status quo, the rate of adoption would be accelerated.  Relative 
advantage was explored by asking participants about the perceived advantages and 
disadvantages of using managerial epidemiology for decision-making.  The findings 
demonstrate no disadvantages of using the practice of managerial epidemiology for 
decision-making.  Importantly, managerial epidemiology provides objectivity for 
decision-making which was viewed as better than the current subjective decision-making 
process based on individual experiences.  The favorable perceptions suggested the 
adoption of managerial epidemiology should be more rapid based on the attribute of 
relative advantage.  However, adoption of managerial epidemiology was found to be 
variable.  Therefore, the findings of this study cannot support the attribute of relative 
advantage confidently.  
The attribute of compatibility describes if the innovation fits well with the current 
norms to understand the speed and needs of the adoption (Rogers, 2003).  Literature 
shows that incompatibility will slow adoption (Rogers, 2003).  Compatibility was 
explored by asking the participants about the alignment and misalignment of managerial 
epidemiology with current norms and ambulatory health services leadership roles. For 
managerial epidemiology, I found alignment by the expressed criticality.  Participants 
suggested the critical nature of managerial epidemiology superseded any potential 
misalignments, if there were any.  Almost all participants responded that there were not 
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any misalignments of managerial epidemiology with current norms.  Although this 
suggests high compatibility and indicates the rate of adoption should not be hindered 
based on compatibility; the current adoption of managerial epidemiology is variable. This 
study cannot confirm or support the attribute of compatibility.  
As shared in Chapter 2, complexity is the perception of how difficult the 
innovation is to utilize and understand (Rogers, 2003).  This was explored with 
participants by asking about the difficulties for using managerial epidemiology.  This 
study found key challenges with data as well as the gap in leadership competency.  
According to literature, this complexity slows the adoption rate of an innovation such as 
managerial epidemiology.  Since the current adoption of managerial epidemiology is 
variable, this study supports the attribute of complexity.  
Lastly, the attribute of trialability is used to understand if the innovation can be 
viewed by the adopters to understand the results and benefits of the innovation in order to 
help with adoption (Rogers, 2003).  The uncertainty of an innovation such as managerial 
epidemiology is reduced through use of trials (Rogers, 2003).  For managerial 
epidemiology, this attribute was considered in the study by understanding how 
ambulatory healthcare leaders could trial the use of managerial epidemiology.  The study 
concluded that a pilot or small intervention was readily desired and easily feasible.  In 
comparing to the literature, the rate of adoption of managerial epidemiology should be 
enhanced with the attainable trialability.  However, the current adoption of managerial 
epidemiology is variable; therefore, the study cannot support the attribute of trialability.   
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The findings of this study could not support all attributes of DoI theory because of 
the variable adoption of managerial epidemiology currently.  Based on the findings in this 
study for the attributes of relative advantage, trialability, and compatibility, the adoption 
rate should be accelerated.  However, it is evident that complexity is supported by this 
study and may present a challenge for the rate of adoption that leads to variable adoption.  
Though, observability was a DoI component unable to be explored at the time of the 
study and is suspected to be one of the barriers for adoption rate because of the lack of 
ability to observe managerial epidemiology and the results due to the poor adoption.  On 
the other hand, the participants mentioned a recommendation for ambulatory healthcare 
leaders to learn from other leaders and their wins from using this practice as a way to 
improve adoption.  This suggests that observability could be possible in some situations. 
Additionally, the literature noted that particular individual characteristics could 
impact the rate of adoption (Rogers, 2003).  This is similar to the response of Participant 
1 relating to generational and personality differences interplaying with the adoption of 
managerial epidemiology.  Though, the participant pool was diverse in education, 
experience, and individual characteristics. Furthermore, the years of experience did not 
correlate with adoption of the managerial epidemiology.  The median amount of 
experience for the participants was 11 years.  Even still, no notable differences in 
adoption, awareness or competency of managerial epidemiology was found to be based 
on years of experience or education. The adoption was not hardwired among the 
participants and adoption was inconsistent overall.  This means that the findings and 
recommendations can be translated to all ambulatory healthcare leaders.   
109 
 
Limitations of Study 
One limitation of this study is the exclusion of the fifth element of DoI, 
observability.  Observability was not included in this study because existing literature 
demonstrated the poor adoption of managerial epidemiology.  Therefore, observing this 
practice and the results of using managerial epidemiology would be nearly impossible.  
Another limitation was the necessity to use the telephone for the majority of the 
interviews.  The use of telephone for many of the interviews eliminated the ability to 
understand non-verbal communication (Ravitch & Carl, 2016). The absence of non-
verbal communication during the telephone interviews did limit my full understanding of 
messages conveyed by the participants such as facial expressions which can provide 
emotion or additional context to the data provided.  Two interviews were conducted in 
person which enabled me to consider non-verbal communication during the interview as 
well as potential to build increased rapport with those participants.  Importantly, I did not 
feel the rapport with participants of the in-person interviews differed from those engaged 
via telephone.   
Additionally, the setting of the interviews may have also presented a limitation.  
For example, some participants were completing the interview via phone and were on 
their commute.  It is unclear how their commute or technology could have distracted their 
participation in the interviews and their responses.  Moreover, it was difficult to 
understand the setting of any participant beyond those that disclosed their engagement 
during commutes.    
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Lastly, this study was conducted with healthcare leaders in the ambulatory setting.  
While participants did mention the need for using managerial epidemiology in other 
settings and other leadership roles, generalizing the findings to other health services 
leaders would need to be considered carefully.  One could argue that the core components 
of managerial functions applies to any healthcare leaders as all healthcare leaders are 
serving a population; therefore, managerial epidemiology would also apply to their 
leadership approach and decision-making process.   
Recommendations 
Despite the need for managerial epidemiology and uptake in some academic 
institutions, the literature on managerial epidemiology remains minimal.  Based on the 
existing literature and this study, I provide many recommendations for further research.  
The research recommendations presented here reflect gaps remaining in the literature and 
highlights needs based on current events. 
First, additional research is needed on the steps outlined in Figure 3 for adoption 
of managerial epidemiology.  While the steps are built directly from the study findings, 
the steps themselves should be studied to explore the implementation and effectiveness 
on adoption of managerial epidemiology.  Furthermore, a leadership tool as part of the 
steps for adoption should also be researched and developed as an evidence-based tool.  
Similar to researching the overall steps of adoption provided in Figure 3, testing the 
implementation and effectiveness of a leadership tool itself should be conducted.   
Another recommended research topic on managerial epidemiology is to study the 
fifth component of DoI, observability.  Observability was not studied here because of 
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poor adoption of managerial epidemiology overall.  Once managerial epidemiology is 
more widely adopted from using the steps and findings of this study, the observability of 
managerial epidemiology should be researched to better understand the current adoption 
and other ways to accelerate adoption.  Additionally, the alignment of research questions 
with DoI may suggest the recommendations presented in this study could apply for 
adoption of other innovations in a population of ambulatory healthcare leaders. 
Adoption of this practice of managerial epidemiology has been discussed 
predominantly as a way to impact triple aim.  However, there is a recognized quadruple 
aim that was not discussed in this study or in the literature of managerial epidemiology.  
Specifically, the fourth objective is improving workforce experience.  In congruence with 
this objective, this study noted the use of managerial epidemiology and the objectivity 
provided could benefit ambulatory healthcare leaders’ priorities and workload.  However, 
further research should be completed to explore how using managerial epidemiology 
could improve the leader and care team experience. 
The adoption challenges discussed from this study should be further explored and 
addressed.  Specifically, data integrity, data accessibility, and interoperability challenges 
related to managerial epidemiology in support of population health and overall system 
performance should be studied.  While the data personnel will assist leaders with the 
analysis and support decision-making, this recommendation does not solve the data 
integrity, data accessibility, or interoperability challenges.  In terms of interoperability 
and data usage especially population data in managerial epidemiology, the protections 
and challenges of data privacy should also be explored.  The heightened awareness from 
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the pandemic on the use of managerial epidemiology and the barriers presented for the 
adoption further contribute to the urgency of finding solutions more quickly.   
Given the recent awareness of managerial epidemiology due to the pandemic and 
often the first-time some healthcare leaders are using managerial epidemiology, 
additional research should be conducted to explore healthcare leaders use of this practice 
before the pandemic and after the pandemic.  Alternatively, it is recommended to 
research the use of managerial epidemiology to navigate through the rest of the pandemic 
as well as forecast and plan for reviving the healthcare system to fully operational.  This 
future study could include using managerial epidemiology to understand the impact of the 
pandemic on populations who have experienced reduced access to healthcare services, 
associated health outcomes, and the effect on the healthcare system. 
While literature shows the importance of managerial epidemiology for pandemics 
and health policy, there is more research needed for the use of managerial epidemiology 
by health policy leaders and government agencies.  The earlier comment of using 
managerial epidemiology for before and during the pandemic further underlined the need 
for health policy leaders and government agencies to use managerial epidemiology.  The 
literature discussed the use of managerial epidemiology for pandemic and health policy in 
general such as the use of the Dever model for policy analysis (Fleming, 2015).  
However, there is insufficient knowledge on the adoption or use of managerial 
epidemiology in the public sector or government agencies.  Arguably, the healthcare 
transformation that is discussed in this study can be maximized through public policy.  
Furthermore, this study highlighted government contracts and programs such as value-
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based care models which ambulatory healthcare leaders could use managerial 
epidemiology to support.  One could suggest managerial epidemiology should also be 
used by the government to plan and implement such programs.  On a macrolevel, I 
hypothesize that the improved performance individual health organizations can 
experience by using managerial epidemiology could be experienced on local, state, and 
federal health system levels as well.  For these reasons, the public sector and government 
agencies are unrepresented target audiences in the discipline of managerial epidemiology 
and should be prioritized for further research. 
 This study also uncovered another gap in the literature regarding unconscious 
bias.  While the literature discussed unconscious bias in the epidemiological practices, the 
literature does not discuss the unconscious bias of the leader or data personnel.  This 
challenge was highlighted in this study from a participant response and concern regarding 
populations being left out of analyzed differently which could negatively impact their 
health and healthcare services.  As noted previously, unconscious bias in the healthcare 
profession has been attributed to lower quality of care (FitzGerald & Hurst, 2017).  
Therefore, it is recommended that research is conducted on the role of unconscious bias 
in leaders’ use of managerial epidemiology. 
In addition to exploring unconscious bias of leaders using managerial 
epidemiology, other leadership characteristics should be explored to maximize the shift 
towards a population health approach and use of managerial epidemiology.  This study 
found the participants shared an altruistic trait.  I hypothesize that this trait could be a 
common characteristic needed for a population health leadership approach and supportive 
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of the utilizing managerial epidemiology.  To that end, I suspect there are other 
characteristics and a leadership theory that should be studied to accelerate the use of 
managerial epidemiology and effectiveness of healthcare leaders. 
Lastly, a limitation of this study was the narrow focus on ambulatory healthcare 
leaders.  The findings of this study should be applied to leaders of other settings carefully 
as it is under-studied.  Based on literature, I hypothesize that the findings and managerial 
epidemiology could be translated to all healthcare settings and all healthcare leaders.  
However, this would need to be evaluated through further research. Additional research 
on using managerial epidemiology by hospital leaders should be explored.   
Implications 
The findings of this study are significant for impacting positive social change.  
First, this study validated the use of managerial epidemiology for improving the health of 
our population by providing ambulatory healthcare leaders with this practice to better 
understand the population and their needs in order to be effective in their roles.  More 
specifically, current literature discussed the implementation of managerial epidemiology 
in academic programs for emerging healthcare leaders.  The wait for these healthcare 
leaders to graduate and use managerial epidemiology to impact the population’s health 
could be long.  By studying the adoption of managerial epidemiology for the current 
workforce, the recommendations can be implemented more readily in the healthcare 
system rather than waiting for graduates to diffuse the practice.  This could simply take 
many years to impact change; whereas, supporting the current ambulatory healthcare 
leaders to use managerial epidemiology could impact change now, have the most impact, 
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and not delay the improvement of the population's health.  That is provided by this 
study’s findings. 
In this study and the literature, managerial epidemiology is shown to be impactful 
on the triple aim.  More specifically, the use of managerial epidemiology can improve the 
access to healthcare services based on the needs of the population.  Furthermore, the use 
of managerial epidemiology can reduce costs to patients and the healthcare system 
overall.  Additionally, managerial epidemiology can provide leaders with insights to 
improve the quality of care provided to the patients they serve.  From this study, the 
adoption of managerial epidemiology by ambulatory healthcare leaders should be rapid.  
The rapid adoption potential of managerial epidemiology and its impact on the triple aim 
as well as overall healthcare system performance proves to be promising for the health of 
our nation and its struggling healthcare system.  Moreover, this study provided 
managerial epidemiology as a solution for ambulatory healthcare leaders wanting to 
make an impact but grappling with the triple aim and many often-conflicting priorities.  
This study provided steps to accelerate the adoption and highlighted the use of 
managerial epidemiology during a pandemic which has worldwide health implications on 
improving health and performance of healthcare globally. 
Conclusion 
Further spotlighted by the COVD-19 pandemic, the health of our nation is 
dependent on the practice of managerial epidemiology.  While textbooks and curricula 
have been developed for students and newly emerging healthcare leaders, this is the first 
study to explore and discuss how essential the adoption of managerial epidemiology is by 
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the existing workforce of ambulatory healthcare leaders.  This study validated and 
elaborated on the importance of managerial epidemiology.  This study also found that 
managerial epidemiology is critical without any disadvantages for ambulatory healthcare 
leaders and supports healthcare transformation including population health and value-
based care models, improvement of the triple aim, and overall healthcare system 
performance.  From this study, I provided clear steps for hardwiring adoption of 
managerial epidemiology by current ambulatory healthcare leaders.  I also shared 
examples for using managerial epidemiology including application in organizational 
strategic planning, operating planning, and leadership goal setting.  Lastly, I have 
provided numerous recommendations for additional research needed in the discipline.  In 
the light of the pandemic, an important recommendation is the need for studying 
managerial epidemiology in public policy and the public sector to protect the 
population’s health and impact the performance of the entire US healthcare system. 
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Appendix A: Interview Guide 
 Interview Opening: 
The researcher will begin by providing an introduction.  The researcher will thank 
the participant for their engagement and share the purpose of the study.  A review of the 
recruitment content will be provided.  The researcher will reiterate the voluntary, 
confidential nature of the study as well as review the consent form with the participant 
that was emailed or signed in-person prior to the start of the interview.  The process of 
the study will be shared.  Clarification of the key concept definitions will be reviewed.  
The researcher will request the use of a recording device for the interview.  Lastly, the 
researcher will ask if the participant is comfortable and if there are any outstanding 
questions before the interview begins.  The interview will start using the following 
background questions: 
 
1. Start with background questions to build rapport and learn more about the 
participant 
a. What is your full name?  (Researcher should remind that this will not be 
included in the study) 
b. What type(s) of ambulatory setting is your leadership experience in? 
c. How many years of experience do you have in healthcare leadership?  
i. How many of those years are in ambulatory settings? 
d. What is your educational background?   
e. Tell me about your healthcare experience and journey into leadership. 
f. What keeps you energized and engaged in healthcare leadership? 
2. How would the use of managerial epidemiology be an advantage to ambulatory 
health services leaders?   
3. How would the use of managerial epidemiology be a disadvantage to ambulatory 
health services leaders?   
4. In what ways would managerial epidemiology benefit the decision-making 
process in healthcare organizations? 
5. How does/would the practice of managerial epidemiology fit (be compatible with) 
within current ambulatory leadership and management role?   
6. How does/would the practice of managerial epidemiology fit (be compatible with) 
within current ambulatory leadership and management decision-making?   
7. How is the practice of managerial epidemiology misaligned with current norms? 
8. What are your perspectives of the difficulty for ambulatory leaders in using 
managerial epidemiology?   
9. How could these difficulties be mitigated for integration of managerial 
epidemiology in ambulatory leadership practices? 
10. In what ways could you easily test the use of managerial epidemiology in your 
regular work? 
11. In what ways have you used managerial epidemiology in your leadership 
approach? 
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12. What ways are you or your organization addressing population health? 
a. How are you or your organization identifying the populations to address? 
What factors are you evaluating? 
 
